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SUMMARY
The cell type exclusively dealt with in this 
thesis is the human blood neutrophil, which is also 
referred to in the text as polymorphonuclear leuko­
cyte (PMN).
The experimental work in this thesis has been 
accomplished using one immunological and a number of 
biochemical investigative techniques. The former is 
the Boyden technique (Boyden, 1962) for the 
quantitative assessment of leucocyte motility.
This technique has been applied according to the 
method of Boyden in conjunction with the modified 
intra-filter procedure described by Zigmond and 
Hirsch (1973). Biochemical techniques have been 
used to evaluate neutrophil intracellular cyclic 
nucleotide levels, glycolysis and hexose monophosphate 
shunt activity (HMP or HMS).
This thesis is comprised of two main parts.
The first part is a literature review consisting of 
three chapters. These are a brief historical review, 
a discussion of previously described experimental work 
relating to biochemical events associated with cell 
motility and finally, current investigative filter 
methodology in leucotaxis. The second part is experi­
mental and consists of six chapters. The first chapter 
of part two describes the techniques and methods employed 
in the subsequent experimental work. The following
three chapters describe the effects of cyclic nucleo­
tides and various agents which promote alterations 
in their intracellular levels on neutrophil motility. 
Particular attention has been devoted to histamine 
and levamisole since the former has been reported to 
mediate substantial inhibition of neutrophil chemo- 
taxis, a finding which may have clinical significance 
(Hill and Quie, 1975); the latter drug has been 
reported by many authors to promote stimulation of 
various immune functions. The penultimate chapter 
describes the effects of the cyclic nucleotides and 
various drugs which enhance their intracellular 
accumulation,and leucoattractants on neutrophil glyco­
lysis and HMS activity.
Using the technique of Ziamond and Hirsch (1973) 
which enables an analytical dissociation of random from 
directed movement, it has been possible to demonstrate 
that cyclic 3' - 5'-adenosine monophosphoric acid 
(cAMP) and cyclic guanosine 3' - 5'-monophosphoric 
acid (cGMP) per se have no effects on neutrophil motility. 
On the other hand agents which cause elevation of 
intracellular levels mediate profound effects on 
motility. cAMP elevating agents cause a stimulation of 
random motility and chemokinesis (stimulated random 
movement) with an accompanying inhibition of directional 
motility (chemotaxis). Drugs which cause elevation of 
cGMP levels are either without effect or cause stimula­
tion of all three types of movement. Cyclic nucleotides
and the various drugs had no effect on neutrophil 
glycolysis. However, cAMP elevating agents all 
caused a marked inhibition of PMN HMS activity, 
cGMP elevating agents caused a variety of effects 
on HMS activity.
The two leucoattractants used in this study, 
endotoxin activated serum (EAS) and alkali hydro­
lysed casein exerted a dissimilar profile of 
effects on neutrophil biochemistry. EAS promoted 
an early increase in neutrophil cAMP levels and 
stimulation of both glycolysis and HMS activity. 
Casein, on the other hand, had no effects on cAMP 
levels and glycolysis and caused a depression of 
HMS activity.
Experimental results are discussed at the end 
of each chapter and the final chapter presents an 
overall discussion designed to co-ordinate the 
results of the previous four chapters.
For much of this presentation the term "chemo- 
taxis" is used inaccurately. This is unavoidable 
since much of the literature reviewed assumes that 
effects observed on neutrophil motility in positive 
gradients can be attributed to alterations in 
chemotactic responsiveness, without dissection of the 
various types of motility which could be influenced.
P A R T I
Historical Background
HISTORY OF LEUCOTAXIS
The term "chemotaxis", with reference to directed 
movement of leucocytes, was first used by Leber in 
1888 who clearly showed the "directed" movement of 
leucocytes towards a number of biologically derived sub­
stances, such as bacteria and fungi, animal tissue 
putrefaction products and water and alchoholic extracts of 
Staphylococcus aureus, Accumulation of leucocytes at 
the site of the chemoattractant substance was accomplished 
by injecting the test substance into the cornea or 
anterior chamber of the eyes of frogs and rabbits. In 
other experiments chemotactic substances were placed in 
capillary tubes and introduced into the anterior chamber 
or iiito the peritoneal cavity of rabbits with accompanying 
subsequent leucocyte accumulation.
In order to ascertain that leucocyte movement was
actually directed and not a random movement, Lener injected
test substances into the cornea of a guinea-pig and when
some leucocyte accumulation was apparent to the naked eye
the affected area was excised and examined microscopically
0in a moist chamber at 37 C. In this fashion continuous 
cell movement could be observed for some hours and Leber 
observed leucocyte movement towards the test substance•
Comandon (1919) devised an in vitro technique to 
demonstrate leucocyte chemotaxis. This method consisted 
of spreading a thin film of blood between a slide and 
cover-slip and recording leucocyte movement by time- 
lapse cinematography. Comandon demonstrated that avian
2.
leucocytes were attracted towards avian red cells 
parasitized with Haemamoeba danilewski. The leuco­
cytes apparently exerted pressure on the red cells 
until they burst and the polymorphonuclear leucocytes 
subsequently phagocytoced the parasite and the red 
cell debris. Similar behaviour was shown by human 
leucocytes towards red cells parasitized with Filaria 
loa. Starch graunles and a variety of bacteria such 
as streptococci, Corynebacteriwi diptheriae and 
Bacillus anthracis were also shown to be chemotactic 
for human leucocytes.
A further ccntribution to the in vivo study of 
chemotaxis was made by Clark and Clark (1921 and 1922). 
Substances under investigation with regard to leuco- 
tactic poential were introduced into the transparent tail 
of a tadpole either by injection as minute droplets or 
within small capillaries. The tadpole was anaesthetized 
in a special chamber which enabled continuous microscopic 
examination of the tail over long periods of time. 
Accumulation of leucocytes was observed to occur with a 
large variety of chemotactic substances including 
bacteria, starch, agar and gelatin.
Wright in 1921 introduced an in vitro technique 
designed to test chemotaxis. This method consisted of 
saturating a square of blotting paper with the test 
substance, covering it with a drop of blood and incubating 
for a given period of time subsequent to which the 
blood was washed away and the number of leucocytes which 
had been retained was microscopically eva.1"34'0'1 T V .  -i r-
method inherently contained many variables and was 
considered unsatisfactory.
McCutcLeon and Dixon (1936) using the cover- 
slip technique of Comandon tested the chemotactic 
response of human leucocytes towards a variety of 
bacteria including Gram positive, Gram negative and 
acid-fast bacilli and found the same intensity of 
response in all cases. All the leucocytes within a 
certain range of the bacterial clump moved directly 
towards it. A predominantly polymorphonuclear leucocyte 
response was evident.
Karris in 1952 introduced another technique for 
demonstrating chemotaxis. A random dispersion of 
variable human polymorphonuclear leucocytes was obtained 
by a modification of the method originally advocated by 
Wright. A drop of bl<~>od was placed on a cover-slip and 
incubated for about one and a half hours at 37°C in a 
moist chamber. During the incubation period a large 
number of the leucocytes in the blood clot adhered to the 
cover-slip and remained adherent subsequent to removal 
of red blood cells and serum by washing. Adherent leuco­
cytes were incorporated in a thin plasma layer which was 
allowed to clot between the cover-s)ip and a microscope 
slide. Test substances which were solid or semi-solid 
were placed on the slide in contact with the plasma layer. 
When the test substance was a fluid it was incorporated 
onto a drill-hole on a perspex slide and thus came into
4.
contact with the plasma layer. In this way test 
substances were localised at a given point on the 
plasma film. Leucocytes, when incubated at 37°C, 
left the glass surface to which they were previously 
adherent and moved freely in the plasma film.
Movements of leucocytes towards test substances were 
recorded photomicrographically and the paths taken 
by moving leucocytes registered on the negative as 
traces.
When the leucocytes moved at random the traces were 
irregular and apparently non-directed. However, a chemo 
tactic response was characterised by a convergence of 
traces towards the test substances. In this way various 
bacteria and starch grains were found to be chemotactic.
In 19 53 Rebuck and Crowley described "the skin 
window technique". 'ihe skin of the upper forearm was 
abraded and overlaid with a glass coverslip. The cover 
slip was removed at hourly invervals and replaced by 
another coverslip. Each coverslip was fixed and stained 
and the number and type of adherent ceils was enumerated 
microscopically. This technique gave an estimation of 
in vivo cell movement. The skin window gives an assess­
ment of the quality of the leucocyte migration with 
regard to appearance and predominance of a particular 
cell type at a given time.
The previously described work is selective with a 
view to indicating work which may have been of a con­
tributory and relevant nature prior to 1962. Harris in 
1960 described the history of leucocyte chemotaxis as
5being "studded with more picturesque names than solid 
facts". Prior to 1962 literature pertaining to 
leucocyte chemotaxis was more suggestive than precise. 
Techniques both in vivo and in vitro, although 
intriguing, were often highly intricate and difficult 
to interpret. Conclusions implicating a "chemotaetic 
response" of certain white blood cell types to certain 
"chemotactic substances" could certainly be made, but 
a quantitative assessment of such responses was 
totally impossible. The aforementioned and related 
studies of movement of different cell types created an 
awareness of the phenomenon of directed cell movement 
and of the attractant substances capable of initiating 
sucn movement. In particular, there was no satisfactory 
evidence to implicate leucocyte chemotaxis as an 
important primary host defence mechanism.
The advent of a reliable quantitative in vitro 
technique for the evaluation of chemotaxis was 
considered essential to clarify an obscure situation. 
It was not until 1962 that Boyden described the first 
accurate technique for the assessment of chemotaxis. 
Ingenious in its conception, the actual test apparatus 
was fairly simple, comprising a vertically bicompart- 
mental chamber in which the upper and lower chambers 
were separated by a millipore filter. The pore size of 
the filter is determined by cell size such that cells
6.
could migrate through actively but not drop passively.
A numerically standardized cell suspension vas 
placed in the upper compartment of the chamber and 
soluble chemotactic substances placed in the lower 
chamber. The chambers were subsequently incubated 
and the cells allowred to respond chemotactically.
After a suitable time interval the filter was fixed 
and stained and the lower surface examined micro­
scopically. Chemotaxis was evaluated by counting 
those cells which had completely traversed the filter. 
This technique permitted quantitation of ce^l respon­
siveness to a known chemotactic factor and conversely 
the assessment of the chemotactic potential of a 
fluid by its capacity to induce chemotaxis.
In his studies Boyden investigated the ability of 
rabbit peritoneal polymorphonuclear leucocytes (PMN) 
to migrate actively towards rabbit sera which had been 
"activated" by immune complexes and aggregated gamma 
globulin.
This method,which made it possible to perform 
numerous assays on a given day with a fair degree of 
accuracy, has yielded much information on the chemo­
tactic process. The existence of inany leucoattractants 
and of the various leucocyte types capable of initiating 
a chemotactic response has been well documented.
7.
The phenomenon of recurrent infection had not 
hitherto been associated with defects in leucocyte 
motility. The micropore filter technique has found 
immediate application in the study of human diseases.
The category of recurrent infections of humans has 
come under re-investigation. Chemotactic defects 
have often been found and may be either humoral or 
cell associated.
The various modes of generation and diverse 
nature of chemotactic factors together with a 
description and classification of types of defective 
leucotaxis in human disease have been previously 
described (Anderson, 1974). For this reason they 
will not be discussed in this thesis.
Biochemical fractionation of complex mixtures found 
to induce a chemotactic response in the Boyden system 
has resulted in the acquisition of biochemically pure 
preparations of leucoattractants. In vitro interaction of 
these with the appropriate cell type, in conjunction with 
measurement of specific biochemical responses has been 
informative with regard to the cellular biochemistry 
associated with chemotactic stimulation.
Revitalised interest in the field "of leucotaxis has 
occurred over the past decade, and accordingly major 
advances are limited to this period. For this reason it is 
intended to devote the remainder of this introduction to 
a review of the literature pertaining to the cellular 
biochemistry of leucotaxis subsequent to 1962.
C H A P T E R  il
Biochemistry of the Neutrophil
Chemotactic Response
EVENTS OCCURRING AT THE CELL MEMBRANE
a) Relationship 01 leucotactic potential to molecular
hydrophobicity
Wilkinson (1971, 1972, 1973 and 1974) has demonstrated 
that increases in molecular hydrophobicity, induced by a 
variety of chemical treatments, correlate with enhanced 
leucotactic activity of such structurally altered molecules. 
The acquisition of such activity can be accomplished by 
acid-alkali denaturatio.n and reduction-alkylation treatment 
of human serum albumin (HSA) (Wilkinson 1971 and 1974); 
by removal of the haem moieties from haemogloblin and myo- 
globlin, a procedure which increases the net surface 
hydrophobicity of these molecules (Wilkinson 1973); and by 
conjugation of non~polar side groups to the HSA molecule 
(Wilkinson and MacKay, 1972). The same author postulates 
tha’t molecular denat.uration in aqueous solution is 
accompanied by a transposition of hydrophobic groups from 
the molecular interior to situations of increased surface 
exposure. Exposure of such groups would lead to an 
increase in the overall hydrophobic properties of the protein 
molecule and an increase of molecular surface activity. Such 
surface active proteins could be expected to manifest high 
affinity for cell surfaces. Schiffman et at (1975) have 
reported that certain synthetic small peptides with an N- 
terminal formyl methionine residue possess leucotactic 
activity. Showell et at, (1976) using a variety of such 
synthetic di-, tri-, and tetrapeptides with an N-terminal
9.
formyl methionine have demonstrated that such peptides
are truly chemotactic. The leucotactic activity
is dependent on the nature of the amino acid components.
Peptides containing non-polar amino acids possess
greatest leucotactic potential. Those containing a C-terminal
phenylalanine are particularly effective.
b) Cell membrane changes mediated by chemotactic
factors
Gallin et al3 (1975) have reported that certain neutrophil 
chemotactic factors such as C5a derived by immunological 
or enzymatic cleavage of the fifth component of complement 
(Snyderman et al3 1969) dialysable transfer factor (Gallin and 
Kirkpatrick, 1974) kallikrein and plasminogen activator 
Kaplan et al3 1972) mediate a diminution of the negative 
surface charge of human neutrophils as measured cytophoro- 
metrically. Such changes cannot be mediated by other proteins, 
which are apparently non-chemotactic. No correlation was 
evident between the extent of the chemotactic response and 
reduction of cell surface negativity between the various 
leucoattractants. However, marked correlation was evident 
in C5a dose response experiments where increasing chemotaxis 
was associated with decreasing cell surface negative charge.
The authors suggest that the decreased surface charge 
enhances cell adhesion and is a prerequisite for locomotion.
The authors in support, cite the work of Nagura et al3 
(1973) who showed that treatment of rat macrophages with 
poly-electrolytes which decrease cell surface charge,
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facilitates particle attachment during phagocytosis. 
However, Hardy ei at 3 (1976) have reported that enhanced
phagocytosis is associated with increased cell surface 
charge. An inverse relationship between cell surface 
negativity and cell adhesion has been reported for 
amoebae by Ambrose and Forrester (1968) and for bone 
marrow granulocyte precursor cells by Lichtman and Weed 
(1972). Other authors, however, are in disagreement 
with these findings. Lomnitzer et at3 (1976a) have also
reported that a chemotactic factor, endotoxin activated 
fresh human serum (EAS) mediates a reduction of cell 
surface negative charge as assessed by a cytophorometric 
technique. These authors, however, were unable to 
demonstrate any detectable change in cell surface charge 
by agents which inhibit neutrophil glass adherence. 
Furthermore, leucocyte inhibitory factor (LIF) which 
specifically inhibits human PMN migration (Rocklin, 1974) 
by promoting increased ceil adherence .(Lomnitzer et at3 
1976b) causes an increase in cell surface charge 
(Lomnitzer et at3 1976c). The effects of LIF on neutrophil 
motility are Currently under investigation in several 
laboratories and preliminary data from this laboratory 
indicate that LIF may cause inhibition of cell motility.
The relationship of surface charge to cell motility 
is somewhat obscure. Depression of cell surface negative 
charge by leucoattractants is evident and may indeed be 
a prerequisite for chemotaxis (Gallin et at3 1975 and 
Lomnitzer et at, 1976a) and LIF, an agent which causes 
increased cell surface charge, mediates an inhibition of 
cell motility (Lomnitzer et at3 1976c) . Presumably
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adherence to an appropriate surface is essential for 
cell motility. Atherton and Born (1972), in anJmal 
experiments, have demonstrated the importance of 
granulocyte adhesion to the vascular endothelium for 
initiacion of in vivo leucocyte emigration from 
venules. However, the degree of adherence in relation 
to the rate and extent of cell motility has not been 
elucidated.
c) Requirement of Divalent Cations Mg++ and Ca++
for Cell Motility
Bryant and Sutcliffe (1972) have reported that leuco­
cyte adhesion is dependent upon the presence of MgTT and 
can be abolished by EGTA which specifically chelates this
cation. There was no requirement for adhesion of Ca++,
+ +K and Na . These findings have been confirmed by Lomnitzer
et al3 (1976b). Becker end Showell (1972) demonstrated a
++ ++requirement of both Ca and Mg in the external medium 
for a maximal chemotactic response. This has been confirmed 
by Gallin and Rosenthal (1974), Wilkinson (1975) and 
Estensen et al, (1976).
Johnson et al3 (1970) have reported that divalent 
cation ionophores increase the permeability of cell membranes 
.to divalent cations by forming chelate compounds of a 
hydrophobic nature which facilitate cation trans-membrane 
passage. Ionophores have been used experimentally to further 
elucidate the relationship of divalent cations to cell 
motility. Wilkinson (1975) and Estensen (1976) have reported
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that the ionophore A23187 at low concentrations in the
■ f * 4 *  ~ f" " f *absence of Ca and Mg can mediate a return to normal
neutrophil chemotactic responsiveness. Furthermore
Becker (1975) has shown that A23187 in a Ca++ free
medium causes a stimulation of random and directed
motility, which has been confirmed by Estensen et al3
(1976). Although there is agreement as to the requirement
++ ++in part of external Ca and Mg the ionophore studies 
indicate that ion influx is of importance in cell motility. 
Gallin and Rosenthal (1974) have shown that various leuco- 
attractants, upon interaction with human neutrophils, 
mediate a rapid release of radiolabelled Ca++ from neutrophils 
associated with depressed Ca++ uptake and a shift of intra­
cellular Ca++ out of the cytoplasm and into a granular 
fraction. These results are apparently contradictory to 
the ionophore studies. However, comparison is difficult 
since there are no studies pertaining to ionophore mediated 
radiolabelled cation fluxes in chemotactically stimulated 
cells. There is no evidence from the ionophore studies to
suggest that Ca"r+ efflux does not occur during cell motility. 
++Also Ca is only very slightly reduced during the first 10 
minutes of chemotactic stimulation, and indeed the apparent 
reduction of influx could be an artifact of the experimental 
system since no correction has been made for simultaneous 
efflux of radiolabelled Ca++, if this was large enough to 
affect results.
The monovalent cation K+ has been reported by Ward and 
Becker (1970), to be necessary for optimal neutrophil 
migration since ouabain which apparently blocks the 
potassium pump in neutrophils (Woodin and Wieneke, 1970)
causes a K+ reversible inhibition of neutrophil chemo- 
taxis. These findings have been disputed by Ramsey and 
Harris (1973) and Wilkinson (1975).
It is probable that Mg++ is of importance in cell
-f- -f- -f* -f-adhesion and Mg and Ca may regulate intracellular 
processes involved in cell motility.
d) Chemotactic factor activation of membrane esterases
Becker and Ward (1976a) demonstrated that organo- 
phosphorus inhibitors of serine esterases inhibit the 
chemotactic response of rabbit PMN cells to chemotactic 
factors produced by the interaction of immune precipitates 
with 10% rabbit serum. The organophosphorus inhibitors 
employed in the demonstration of inhibition were diisopropyl- 
phosphofluoridate and a series of homologous phosphate 
esters which varied in alkyl nature of the first carbon 
atom. Two types of inhibition were demonstrable. The first 
was termed by the authors "cell-dependent inhibition", in 
which elimination of chemotactic responsiveness was 
attained by incubating PMN cells with a phosphate 
inhibitor in the absence of chemotactic factors for one 
hour. Cells were subsequently washed free of inhibitor 
and were shown to be chemotactically unresponsive.
Inhibition was time dependent, being normal at one hour. 
Inhibitor concentrations required to eliminate cellular 
responsiveness varied with phosphonate ester type.
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The second type of inhibition observed was termed 
"chemotactic factor-dependent inhibition" and was 
demonstrated by assessing the chemotactic responsiveness 
of PMN cells suspended in appropriate concentrations of 
a phosphonate ester. To avoid loss of chemotactic 
activity due to cell-dependert inhibition, the concentra­
tion of inhibitor, phosphonate type and duration of cell- 
inhibitor contact were manipulated to minimize this effect 
Inhibition, in the presence of chemotactic factor, was 
obtained at concentrations of phosphonate inhibition which 
cause negligible or non-existent cell-dependent inhibition 
whilst manifesting a high level of inhibition apparently 
mediated by the interaction of chemotactic factor with 
the PMN cell.
It was concluded that these two typ s of inhibiti 1 
were due to the inactivation of two PMN serine esterases. 
The cell-dependent type was attributed to the inhibition 
of the "activated esterase", as termed by the authors.
It is postulated that this esterase exists in or on the 
PMN cell in an already activated state and is therefore 
susceptible to phosphonate inhibition in the absence of 
chemotactic factor. Chemotactic factor-dependent 
inhibition is considered due to the inhibition of a 
second esterase termed the "actlvatable esterase".
Becker and Ward speculate that this enzyme is present in 
or on the cell in precursor form, which is not susceptible 
to inactivation by the organophosphorus inhibitor. 
Hypothetically the chemotactic factor would cause
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activation of this esterase with concomitant 
conversion to inhibitor susceptibility.
Subsequent work contributed to a further 
characterization of the two esterases. Becker and 
Ward (1967b) demonstrated that carboxylic acid 
esters afforded protection against the inhibition 
of the activated esterase of chemotuxis by phos- 
phonate esters. Degree of protection was dependent 
upon the relative concentrations of protective ester 
and inhibitor. Protective esters also inhibit chemo- 
taxis and the authors postulate that the carboxylic 
acid ester competes with the phosphonate for the 
enzymatic site of the activated esterase.
Requirement of a high degree of specificity of 
the structure of the protective ester was evident.
The ester must be an acetate esterified to a negatively 
charged or neutral group. Experiments indicated that 
the cell-bound activated esterase is able to bind the 
protecting ester to the enzyme active site. That the 
enzyme was capable of ester hydrolysis was undetermined. 
Differences in inhibition profiles indicated tnat the 
activated esterase was not the known aliesterase of 
rabbit leucocytes.
The authors conclude "that the activated esterase of 
chemotaxis is an enzyme capable of being competitively 
inhibited by, or of hydrolyzing neutral acetate esters, 
and acetates bound to negatively charged groups, or of 
doing both". They postulate that such characteristics
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are indicative of the properties of an acetylase.
.Ward and Becker in 1968 first demonstrated the 
phenomenon of "deactivation",'whilst further charac­
terizing the activatable esterase of chemotaxis. They 
demonstrated that incubation of rabbit PMN cells with 
30% rabbit serum for sixty minutes eliminated cell 
responsiveness to a chemotactic stimulus. Similar 
observations were made when cells were pre-incubated 
with "purified" C567. This phenomenon of inhibition 
of leucotaxis by interaction of chemotactic factor 
with PMN cells prior to chemotactic evaluation was termed 
deactivation. Phosphonate esters prevented deactivation 
and also prevented chemotaxis. The profiles of pro­
tection against deactivation were similar to those cf 
chemotactic-factor dependent inhibition suggesting that 
the actjvatable esterase was involved in both cases.
Acetate esters, previously shown to inhibit the 
action of the activated esterase, did not prevent de­
activation. The only other substances found to prevent 
deactivation were aromatic amino acid derivatives. The 
protection afforded by these was specific insofar as 
nonaromatic amino acid compounds and simple acetate esters 
hab no effect. In conjunction with these and previous 
findings, the authors suggest that "the activatable 
esterase of the rabbit PMN is a serine esterase with a 
special affinity for aromatic amino acid derivatives".
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Becker and Ward (1969) demonstrated that the rabbit 
peritoneal PMN cell contains 3 esterases capable of 
hydrolyzing the aromatic amino acid ester acetyl DL- 
phenylalinine naphthyl ester. Two of these esterases, 
termed esterase 1 and 2 are inhibited by phosphonate 
esters. Esterase 3 is not inhibited. Using inhibition 
profile studies the authors concluded that esterase 1 
is the activated form of the activatable esterase of 
chemotaxis (proesterase 1).
Becker (1972) demonstrated that C3a, C5a and C567 
of human origin and bacterial chemotactic factor (Ward,
1968a) show identical profiles of inhibition of chemotaxis 
by phosphonate esters. This apparently indicates that 
induction of chemotaxis by these 4 chemota tic factors 
involves activation of proesterase 1 of the rabbit PMN 
cell.
C567, C5a and C3a activated proesterase 1 of rabbit 
peripheral blood leucocytes. No activation was observed 
with rabbit peritoneal PMN cells. The decreased esterase 
of the latter cells may be attributable to partial 
"deactivation". These cells had previously migrated to the 
peritoneum in response *-o glyccgen stimulation and may have 
exhausted some of their chemotactic potential. Bacterial 
chemotactic factor did not activate preesterase 1 of rabbit 
peripheral blood PMN cells. This may indicate a difference 
in mechanism of the two types of chemotactic factor. The 
difference may however be of a quantitative nature. Bacterial 
chemotactic factor exhibits a much lower chemotactic activity
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than C3a, C5a and C567.
The author concludes that activation of proesterase 1 
is a prerequisite for the cheraotactic activity of rabbit 
PMN cells and suggests that under several different 
circumstances the level of chemotactic activity attained 
is related to the degree of such activation.
These findings have been disputed by Todd and Dowdle
(1973) who failed to detect esterase activity in
rabbit peritoneal PMN cells stimulated with the leucoattrac- 
tant casein. The studies of Becker and Ward would be a 
great deal more convincing if they could assert the 
specificity of the esterase inhibitors. This could be 
accomplished by demonstrating absence of interference with 
neutrophil metabolic pathways essential for optimal cell 
motility such as glycolysis (Carruthers, 1966; Goetzl and 
Austen, 1974) and the hexose monophosphate shunt (HMS)
(Goetzl and Austen, 1974). Indeed, Goetzl and Austen
(1974) have reported that diiscpropylf1uorophoephate (DFP), 
one of the serine esterase inhibitors used by Becker and 
Ward (1967a), mediates substantial, progressive dose 
dependent inhibition of glycolysis at concentrations of 10 ~*M 
upward^. In their experiments Becker and Ward (1967a) used
-3DFP concentrations of 1 - 5 x 10 M to attain inhibition of 
chemotaxis. Such concentrations would be expected to 
mediate considerable inhibition of glycolysis. This 
possibility would cast doubt upon the validity of the con­
clusions of Becker and Ward (1967a) with regard to the role 
of serine esterases in neutrophil motility.
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Goetzl (1975) has reported that the synthetic 
esterase inhibitors L-l-tosylamide-2-phenylethyl- 
chloromethyl ketone (TPCK) and N-a-p-tosyl-L-lysine- 
chloromethyl-ketone (TLCK) cause an inhibition of 
chemotaxis. The former also inhibits random migra­
tion and the latter affects a mild stimulation. HMS 
activity is unaffected by these inhibitors. However, 
this may not be a valid criterion by which to implicate 
absence of non-specific effects since HMS may play 
little part in directed motility. Childi'en with chronic 
granulomatous disease (CGD) have normal neutrophil chemo­
taxis in the absence of infection, (Gallin, personal 
communication - 1975). (See also Chapter VIII of this 
thesis).
The clinical significance of these studies remains 
undetermined since there have been no reports of defective 
leucotaxis associated with diminished cell esterase 
activity.
Microfilaments and Microtubules
a) Microfilaments: These have been documented in 
many ^ell types and have been identified as actin-like 
polymers of 4-7 run diameter. Actin-like microfilaments 
have been associated with many cell activities which 
appear tc involve contraction such as membrane movements 
and cytoplasmic streaming. (Schroeder, 1970; Bradley, 
1973; Allison et at, (1971); Wessels et at, (1971). The
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functional connection between such effects and micro- 
filaments has largely been based on experiments 
involving the drug cytochalasin (Carter, 1972). Since 
the drug appeared to interfere with cell activities 
associated with the presence of microfilaments it was 
assumed by many workers that cytochalasin was a specific 
inhibitor of contractile protein microfilaments.
Cytochalasin in many cases does not enter the cell and 
the primary target may be the cell surface (Sr~ger and 
Holtzer, 1972; Estensen and Plagemann, 1972). Further­
more, Forer et al 3 (1972) reported no interference in
vitro by cytochalasin in actinomyosin interactions or 
transformations.
Becker et al3 (1972) has reported that cytochalasin B 
caused a depression of neutrophil chemotactic responsiveness. 
Zigmond and Hirsch (1972a) found that the same drug mediated 
inhibition of random migration. These findings may implicate 
microfilaments in neutrophil locomotion. Zigmond and Hirsch 
(1972b) have also shown that cytochalasin causes inhibition 
of leucocyte glycolysis, which further emphasises the dubious 
nature of cytochalasin as an investigative tool with regard 
to microfilament participation in a particular cell function.
Keyserlingk (1968) has shown that the broad locomotor 
pseudopods associated with normal neutrophil movement 
contain cortical microfilaments of 6 nm diameter. Further­
more, actin (Tatsumi et al3 1973) and myosin (Tatsumi et al3 
1973; Stossel and Pollard, 1973) have been isolated from 
neutrophils. Using the histochemical technique of
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"arrowhead" formation (Ishikawa, 1969), Pollard and 
Weihing have demonstrated that the cortical micro­
filaments associated with cell motility are actin 
polymers. Boxer et at, (1974) have isolated a 
contractile protein of 42,000 from human neutro­
phils which exhibits the functional properties of 
actin.
Boxer et al, (1976) have isolated pure actin,
myosin and actin binding protein (ABP) in large 
amounts from the leucocytes of patients with chronic 
myelogenous leukaemia. Gel formation a^d contraction 
was evident upon mixing of all 3 proteins in sucrose 
solution. Antibody to myosin caused inhibition of 
contraction, while antibody to ABP inhibited both gel 
formation and contraction.
Neutrophils incubated with antibody to myosin and 
antibody to ABP manifested 70% inhibition and 30% 
inhibition of migration respectively. Immunofluorescence 
studies indicate that ABP is localized on the cell 
membrane.
Micrcfilaments are membrane associated contractile 
elements structured from the protein actin, which 
probably play a major part in neutrophil locomotion, 
which may be accomplished by contraction and relaxation 
of actinomyosin. Contraction of muscle actinomyosin is
-f + +dependent upon adequate concentrations of ATP. K , Ca 
++and Mg and this would indicate the existence of at 
least one intracellular source of requirement of divalent
cations.
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b) Microtubules: These are a class of proteinaceous 
intracellular fibres found in a. wide variety of eucaryotic 
cells. They were originally defined by their morphology 
as viewed electron microscopically (EM), appearing as 
tubules with an outer and inner diameter of 250A° and 
150A° respectively. Since the widespread use of gluta- 
raldehyde as fixative in EM their occurrence has been 
documented in all eucaryotic cells examined (Roberts,
1974).
Microtubules are structured from the protein tubulin 
(Mohri, 1968) which has been shown by Weisenberg et al3 
(1968) to be a colchicine binding protein of M.W. 120,000. 
The protein is a dimer of 2 monomer components both of
M.W. 60,000. Shelanski and Taylor (1968) have shown that 
GTP stabilizes tubulin and that each tubulin dimer has 2 
GTP binding sites and 1 colchicine binding site. Hydro­
lysis of bound GTP is probably related to polymerization 
since no contractile activity has been reported for 
tubulin.
The existence of microtubules in neutrophils has been 
demonstrated convincingly (Malawista and Bensch, 1967; 
Bensch and Malawista, 1969; Gallin and Rosenthal, 1974; 
Malech et al3 1976). Colchicine and vinblastine have 
been shown to mediate disruption of microtubules, in neutro­
phils (Malawista and Bensch, 1967; Bensch and Malawista, 
1969). These drugs also cause an inhibition of neutrophil 
chemotaxis. (Caner, 1964; Phelps, 1970). These findings
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have been disputed by Baum (1975) and Snyderman (1975). 
Russell et al, (1976) have reported that colchicine 
causes a marked inhibition of the true chemotactic 
response as measured by the method of Zigmond and 
Hirsch (1973) but a stimulation of random migration.
These findings suggest a dependence, at least of 
directed motility, upon the presence of intact micro­
tubules .
Gallin and Rosenthal (1974) have reported that 
the leucoattractant C5a, upon interaction with human 
neutrophils causes a substantial increase in the number 
of microtubules as assessed by counting these structures 
on the appropriate electron-micrographs. Malech ei al, 
(1976) have investigated centriole, microtubule and 
microfilament orientation in human neutrophils during 
chemotactic stimulation. This was accomplished by over­
laying neutrophils on a filter of insufficient pore size 
(0,45/Am) to allow intra-filter migration whilst permit­
ting the establishment of a gradient of leucoattractant 
(EAS). Electron-micrographs revealed that those cells 
exposed to a gradient of leucoattractant manifested an 
increase in sub-membrane microfilaments and microtubules. 
These extend radially from centrioles to the cell peri­
phery and into the pseucopods (in agreement with 
Keyserlingk, 1968). This increased cytoskeleton assembly 
was detectable only at the side of the cell exposed to 
chemotactic stimulation. No such organization was 
evident in neutrophils exposed to buffer only.
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In vitro microtubular assembly studies using
tubulin proteins isolated from' brain indicate that
the extent of polymerization is regulated by the level 
H—f~of Ca and the nucleotide triphosphates ATP and GTP
++with optimal polymerization occurring in a low Ca 
environment (Weisenberg, 1972; Berry and Shelanski,
J972; Shelanski et alt 1972; Fuller et al, 1975). 
Furthermore, Fuller et al 3 (1975) have reported that
in vitro assembly and disassembly of cytoplasmic micro­
tubules may be regulated in part through mitochondrial 
sequestration and release of cytoplasmic calcium. Mito­
chondria can take up and release calcium and probably 
act as the organelles which regulate the level of intra­
cellular calcium. Neutrophils, however, show a 
relative paucity of mitochondria (Becker, 1971). Fuller 
et al, (1975) have reported in vitro stimulation of
microtubule formation in intact fibroblasts mediated by 
dibutyryl cyclic adenosine S'1", -5*, - monophosphate 
(d'cAMP). The same authors have also reported that cAMP 
stimulates the calcium pump for rapid Ca++ release. 
Microtubule assembly is almost certainly under the control 
of cAMP and calcium ions.
The relationship between microfilaments and 
^icrotubules in neutrophil motility is uncertain. Gallin 
and Rosenthal have suggested that the "microtubule system 
may provide the net vector of motion (i.e. polarized 
psuedopoa formation), while the microfilament system, 
which may require local increases in Ca++, would provide 
the mechanical work for motion".
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EFFECT OF CHEMOTACTIC STIMULATION ON NEUTROPHIL GLYCO­
LYSIS AND THE HEXOSE MONOPHOSPHATE SHUNT PATHWAY (HMP)
a) Glycolysis: It is unlikely that oxidative 
phosphorylation contributes substantially to the 
energy requirement of neutrophil locomotion due to the 
comparitively low numbers of cytoplasmic mitochondria 
(Becker, 1971). Furthermore, Ward (1966) and 
Carruthers (1967) have reported that dinitrophenol 
(DNP), an uncoupler of oxidative phosphorylation, exerts 
only slight depression of the neutrophil chemotactic 
response. Carruthers (1966) and Goetzl and Austen (1974) 
have shown that inhibitors of glycolysis (iodoacetate and 
iodoacetamide) show a parallel inhibition of glycolysis 
and chemotaxis. Iodoacetamide (Geotzl and Austen, 1974) 
is the more potent of the two inhibitors. Carruthers 
(1967) has demonstrated inhibition of chemotaxis by 
deoxyglucose (an inhibitor of glycolysis). This inhibition 
can be blocked by the addition of glucose. Goetzl and 
Austen (1974) have assessed the effect of the lcucoattrac- 
tants kallikrein and C5a on neutrophil glycolytic activity 
as estimated by lactate production. Both chemotactic 
factors induced a significant increase in lactaLe production 
(25 - 100% stimulation). Glycolysis has therefore been 
implicated, directly and indirectly, as being the major 
source of ATP production for neutrophil chemotaxis.
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b) Hexose Monophosphate Shunt Pathway (HMP)
Goetzl et at, (1973) and Goetzl and Austen 
(1974) have reported that the partially purified 
chemotactic factors C5a and kallikrein mediate 
100 - 600% increases in HMP activity above that of 
the corresponding unstimulated cells. The stimu]ation 
v/as evident at all times tested, being maximal at 
60 - 120 minutes and of a similar magnitude for ad­
herent neutrophils and neutrophils in suspension. The 
increase in HMP activity with time paralells the neutro­
phil chemotactic responsiveness. The metabolic inhibitor 
6-aminoicotinamide which may mediate a selective 
inhibition of the HMP (Ammon and Steinke, 1972) at 10 ^M 
with only minimal inhibition of glycolysis (Goetzl and 
Austen, 1974) causes a concomitant inhibition of chemo- 
taxis of 23 - 45%; the assumption being that the inhibi­
tion is HMP specific. The control systems in the 
experiments involving leucoattractant/HMP interacLions 
would be o^ greater value if the presence of other agents 
in the leucoattractant preparations had been controlled 
for. For example, C5a was prepared by trypsin digestion 
of C5a for 30 minutes followed by trypsin inhibition 
with soya been inhibitor. The effects of C5a and the 
trypsin/soya bean inhibitor complex were not controlled 
for. Similarly, the appropriate controls were omitted 
for kallikrein experiments.
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Goldstein et al, (1975) have reported that bio­
chemically pure C5a caused a stimulation (500%) of 
nitroblue tetrazolium (NBT) reduction by human neutro­
phils with a concomitant 350% increase in HMP activity. 
Enhancement of NBT reduction by normal cells in vitro 
has been convincingly shown to be associated with 
phagocytosis (Baehner and Nathan, 1968) and neutrophil 
HMP activity (Karnovsky, 1968). C5a stimulation of 
HMP activity and NBT reduction occurs in the absence 
of phagocytosis. No parallel studies correlating the 
degree of HMP stimulation and NBT reduction 'ith the 
extent of neutrophil chemotaxis were performed. These 
results are in agreement with those of Goetzl and 
Austen (1974) .
Goetzl et al, (1974) have reported that ascorbic
acid and glutathione which may enhance the oxidation of 
NADPH to NADP+ (De Chatelet et al, (1972), the 
early rate limiting step in the HMP, promote a stimulation 
of neutrophil chemotaxis and random migration (100 - 300%) 
associated with an increase in HMP activity ( 100%) .
The ascorbic acid mediated enhancement of neutrophil 
motility and HMS activity could be completely eliminated 
by 10 ~*M 6-aminonicotinamide. No effect on glycolysis of 
ascorbate acid was evident. No experiments were performed 
to assess the extent of ascorbate stimulation in the 
presence of the leucoattractants C5a and kallikrein. This 
would appear to be an important experiment required to 
detect an increment in leucoattractant associated HMP 
activity attributable to ascorbate. The magnitude of 
such an increment would enable a valid assessment of
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the relationship between ascorbate, HMP activity 
and stimulation of neutrophil chemotaxis,
The work of the above authors (Goetzl et al,
1973; Goetzl et al y 1974; Goetzl and Austen, 1974; 
and Goldstein et aly1915) has implicated HMP 
involvement in neutrophil motility, increased HMP 
activity being associated with an enhanced level of 
motility. However, there is evidence to suggest 
that stimulation of the HMP associated with neutro­
phil locomotion may be coincidental. Goetzl and 
Austen (1974) demonstrated that diisopropylfluoro- 
phosphate (DFP) which causes a suppression of 
neutrophil chemotaxis has no inhibitory activity 
on HMP activity. Gallin has also shown (personal 
communication, 1975) that children with CGD, a condi­
tion associated with impaired HMP activity, manifest 
normal leucocyte migratory responsiveness in vitro.
The relationship of HMP activity to neutrophil motility 
is imprecise.
IN VITRO MODULATION OF NEUTROPHIL MOTILITY BY CYCLIC 
NUCLEOTIDES AND AGENTS WHICH AFFECT THEIR INTRACELLULAR 
ACCUMULATION
a) Cyclic nucleotides as leucoattractants
A number of authors have reported chemotactic activity 
for caMP (Leahy et aly 1970; Ramsey, 1972; Gammow et at, 
1971; Rivkin and Becker, 1976). On the other hand, a
number of authors (Kaley and Weiner,1971; Wissler 
et at3 1972;.and Symon et at, 1972) have been 
unable to detect such activity. It is difficult to 
attribute the discrepancy in results to variations 
in technique since a similar spectrum of neutrophil 
types and filter systems have been used by workers 
in either camp. Of those who advocate that cAMP 
is leucotactic, none have convincingly eliminated 
alternate modes of stimulation of neutrophil motility, 
such as enhancement of random migration, and this is 
one aspect which requires clarification. The cAMP 
controversy may also be related to the low molecular 
weight (351) of cAMP,. which in filter systems may 
diffuse rapidly from the lower to the upper compart­
ment thereby negating the positive gradient. There 
is a paucity of data on the role of cAMP as a leuco- 
attractant.
b) The effect of c'AMP and agents which promote its 
intracellular accumulation on neutrophil migration 
■in vitro
Tse et at, (1972) reported that cAMP (10 ^M - 
1C M^) mediates inhibition of both random and directed 
migration of human blood neutrophils. Dibutyryl cAMP 
and ATP were without effect. Agents which the authors 
claim may mediate a depression of intracellular cAMP 
such as epinephrine, guanosine 5'- diphosphate, 
imidazole and ADP all cause a stimulation of neutrophil 
random motility. Caffeine and 5-hydroxytryptamine 
which may elevate intracellular cAMP cause an 
inhibition of random motility. These agents were not
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tested for their effects on neutrophil chemotaxis. 
Epinephrine has been reported to increase intra­
cellular cAMP in neutrophils by beta adrenergic 
stimulation (Rivkin et at, 1975) although stimula­
tion of the alpha-adrenergic type (Goldberg, 1974) 
may promote the effects observed by Tse and 
colleagues.
The same authors also investigated the effects 
of a series of purine and pyrimidine analogues on 
neutrophil random motility. They observed that the 
purines xanthine, hypoxanthine, adenine and guanine 
and uric acid, mediated enhancement whereas dimethyl 
xanthines (threobromine and theophyline) exerted a 
relatively mild stimulation. Caffeine (trimethyl 
xanthine) as mentioned above, caused inhibition of 
motility. Neutrophil motility was unaffected by the 
pyrimidines uracil and 1,3-dimethyl uracil, although 
thymine (5-methyl uracil) increased motility, indicat­
ing that a substituent at position 5 of the pyrimidine 
nucleus may be a prerequisite for stimulation.
Rivkin et at, (1975) showed that prostaglandins 
(PG) and E^ which mediate a substantial increase in 
neutrophil intracellular cAMP, cause a decrease in 
chemotaxis at a concentration of 2.5 x 10 ^M. Prosta­
glandin F2 was without effect on cAMP levels or 
chemotaxis. The effect of these agents on random 
motility was apparently not investigated. Epinephrine, 
norepinephrine and isoproterenol all promoted elevated 
cAMP levels without effect on chemotaxis. The 
authors state that the effects of these agents on chemo-
taxis and random motility are "variable" but random 
motility results are not shown. Theophylline at 
high concentrations (1 mM -‘8 mM) caused enhancement 
of intracellular cAMP levels with concomitant 
inhibition of directed and spontaneous motility.
Bourne et at, (1973) have been unable to detect 
increases in neutrophil cAMP levels following inter­
action with theophylline in the range used by 
Rivkin et at. They also reported profound inhibition 
of neutrophil post-phagocytic metabolism. These 
observations indicate that the theophylline inhibition 
of motility may not be related to increased intra­
cellular levels of cAMP.
Rivkin et at, also showed that the effects of 
isoproterenol and norepinephrine on cAMP levels and of 
epinephrine on the inhibition of chemotaxis (where 
inhibition was evident) could be blocked by propanolol 
(beta adrenergic blocker) but not by phenoxybenzamine 
(alpha adrenergic bJocker) indicating that these 
effects are mediated via the beta receptor. Cholera 
toxin was also shown to mediate increased neutrophil 
cAMP after a 30 minute lag period which paralleled 
its inhibitory effect on chemotaxis and random motility.
Paradoxically, the same authors, Rivkin and 
Becker (1976) have reported that exogenous cAMP has 
a variable effect on neutrophil chemotaxis but promotes
a stxmulation of random motility at concentrations of
-5 -42 . 5 - 5 x 1 0  M. Dibutyryl cAMP (5 x 10 M -
-31 x 10 M) causes a considerable inhibition cf chemo-
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taxis, but a stimulation of random motility. Both
_3cyclic nucleotides are chemotactic at 10 M. Henion 
et at, have reported that cAMP 1 penetrates cell 
membranes poorly, if at all, compared with d'cAMP 
(the latter being more hydrophobic) and this may 
account for the variable effects of cAMP and the 
high concentrations required to stimulate motility. 
These results would appear to be contradictory to 
those described in the preceding report by the same 
authors (F.ivkin et at, 1S75),
Valone et at , 1974) have observed inhibition 
of platelet random migration by epinephrine and iso­
proterenol. The inhibition can be prevented by 
blockade of the beta receptor, but not by alpha 
receptor blockade. The prostaglandins PGE^ and PGE2 
caused a stimulation of platelet random migration, 
which could be inhibited by indomethacin,
Hill et at, (1375) have reported inhibition of
-4neutrophil chemotaxis by cAMP (maximal at 10 M).
Beta adrenergic stimulation by epinephrine, norepine­
phrine and isoproterenol also caused inhibition of
chemotaxis which was maximal at a concentration range 
-4 -3of 10 M - 10 M for all three agents. The inhibitory 
effect of epinephrine could be eliminated by propanalol, 
although the effects of propanalol per se were 
apparently not controlled for. Phentolamine (an 
alpha receptor blocker) had no effect on the inhibition.
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Phenylephrine, which mediates stimulation of the
alpha adrenergic type, caused an enhancement of
chemotaxis which could be prevented by phentola-
“ 8mine. The prostaglandins PGE^ and PGE^ (10 M -
__ g10 M) mediated a substantial inhibition of chemo­
taxis whereas PGF2, at the same concentrations, 
promoted stimulation. Histamine inhibition of 
neutrophil chemotaxis could be prevented by treatment 
of cells with the drug metiamide, an antihistamine 
which blocks the Hl-receptor site, indicating that 
che histamine effect on chemotaxis is media, ;d via 
the K2-receptor site. Cholera enterotoxin also 
causes inhibition of chemotaxis which can be blocked 
by cholera enterotoxin. No studies were performed 
to determine the effects of these agents on neutrophil 
motility.
Despite some discrepancies there seems to be 
general agreement that the elevated intracellular cAMP 
levels promote inhibition of neutrophil chemotactic 
responsiveness. This can be accomplished in 5 
different ways; by the addition of cAMP; by beta adren­
ergic stimulation; by histamine; by prostaglandins(A^,E^ 
and E2); and by cholera enterotoxin. The effects of 
these agents on nuetrophil random migration is less clear 
since agents which can inhibit chemotaxis such as 
d 'cAMP (Rivkin and Becker, 1976), epinephrine (Tse
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et al3 1972) prostaglandins (Valone et al 3 
Hill et al 3 1975; and Shibuya et al3 1976) and
histamine for eosinophils (Clark et al3 1976) 
can promote stimulation of random motility.
THE EFFECT OF cGMP AND AGENTS WHICH PROMOTE ITS 
INTRACELLULAR ACCUMULATION ON NEUTROPHIL MIGRATION 
IN VITRO
Estensen et al3 (1973) have reported that 8
bromo cGMP and agents which promote increases in 
intracellular cGMP in a variety of cell types 
(neutrophils not included) mediate an enhancement 
of leucotactie responsiveness. The agents used 
were phorbol myristate acetate (PMA), which was 
particularly effective, and acetyl cuoline and 
carbamyl choline. No investigations of the effect 
of rhese drugs on random motility were performed. 
Valone et al3 (1974) have reported that carbachol
(a cGMP stimulant) mediates stimulation of platelet 
random motility.
In a continuation of this research from the 
same laboratory, Hill et al3 (1975) have reported
that imidazole as well as acetyl choline, carbamyl 
choline and PMA, promote an increase in neutrophil 
chemotaxis. The stimulation of chemotaxis associated 
with acetyl choline and carbamyl choline could be 
blocked by the cholinergic inhibitor, atropine. No
mention is made of the effects of atropine per se.
-9 -6Cyclic GMP at concentrations of 10 M - 10 M also
promoted stimulation of chemotaxis. The authors 
have apparently not investigated the effects of 
these agents on neutrophil random motility since 
no data is shown.
These results indicate that agents which 
elevate intracellular cGMP levels cause a stimu­
lation of neutrophil motility. The exact types 
of motility affected remains to be determined.
C H A P T E R III
Current filter Methodology for the 
in vitro assessment of Neutrophil Motility
MILLIPORE FILTER METHODS IK CHEMOTAXIS
1) Boyden's technique for assensing chemotaxis
Stephen Boyden in 1962 described the first 
accurate technique for the in vitro assessment 
of chemotaxis. This method has subsequently 
attained wide acceptance. Although the test 
apparatus has since undergone a number of modj- 
fications designed to increase its reliability, 
the underlying principle, i.e. the migration of 
chemotactically responsive cells through a micro­
pore membrane, remains unchanged.
The "Boyden Chamber" is fairly uncomp.1 icated 
and consists of a vertically bicompartmental 
chamber in v/hich the upper compartment (chamber 'A.') 
is separated from the lower chamber (chamber 'B') 
by a micropore membrane. The pore size of the 
membrane is determined by the dimensions of the 
cell type used in the chemotactic investigation such 
that cells can migrate actively through the membrane 
but not drop passively. The rigidity of the assay 
can be improved by decreasing the pore size and 
increasing the depth of the membrane. The micropore 
membrane is inserted at the junction of the two 
compartments and firmly held in place by a double 
ring of perspex. The base of the ring is lightly 
smeared with petroleum jelly to enhance the bicompart 
mental seal and so prevent interchamber leakage.
A numerically standardized cell suspension is 
placed in the upper compartment of the chamber and a
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soluble leucoattractant in the lower compart­
ment. The extent of leucotaxis is microscopically 
evaluated according to the number of cells which 
have migrated across the filter after a suitable 
time of incubation.
Chamber assembly is accomplished by the intro­
duction of 1.5 ml of test solution into chamber B,
•the apparatus being tipped slightly to avoid air 
bubbles becoming trapped beneath the filter membrane. 
Cell suspension (3.6 ml) is then pipetted into the 
cell compartment (A) simultaneous to the addition of 
the remaining aliquot (1.5 ml) of test solution.
The apparatus is incubated at 37°C in a moist atmos­
phere containing 5% carbon dioxide, for 3 hours.
After this time the filters are inverted and the 
number of cells which have completely traversed the 
filter in response to the leucoattractant are micro­
scopically enumerated.
The inherent principle involved in the Boyden 
chamber is the establishment of a chemotactic factor 
concentration gradient. At the outset of an experi­
ment the chemotactic factor may be completely localized 
in the lower chamber. However, with time, a positive 
concentration gradient develops. Chemotactic factor 
diffuses across the raicropore filter into the cell 
compartment. Chemotactic factor-cell interaction occurs 
in this compartment and a migratory response is induced. 
The extent of cellular migration is dependent on the 
nature of the concentration gradient of leucoattractant. 
Optimal migration is normally induced by positive
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gradients. If the gradient is negatr/e, de­
activation will occur and cell migration is 
reduced.
At the base of the filter, cells can migrate 
no further. Presumably cell retention is dependent 
upon the degree <f cell adherence t the filter.
The extent of cell migration (as measured by the
filter counts) is therefore dependent upon the
rate of cell migration and the level of cell adhesion.
The cell response to chemotactic factors in the 
Boyden chamber is not absolutely uniform, i.e. all 
cells in the upper chamber capable of eliciting a 
chemotactic response do not completely traverse the 
filter. Cells of the same type are seen at both the 
upper and lower limits of the filter and at varying 
intra-filter depths. This suggests a differential 
cellular response to chemotactic factor. Such a 
phenomenon may be due to variations in cellular 
intrinsic chemotactic potential. These may correlate 
with cell maturity or previous exposure to chemotactic 
factor, which may cause a complete or partial deactiva­
tion of the chemotactic response. This could possibly 
account for the various levels of cell migration 
observed in the filter.
Dimensional Modifications of Boyden's System
Early modifications of Boyden's technique were 
mainly devoted to minimizing the cellular and chemo-
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tactic factor requirements demanded by this system.
gUpwards of 5 x 10 PMN cells in 3.5 ml of medium 
and 3 ml of chemotactic factor were required. 
Situations in which the leucoattractant potential 
of a fluid was under assessment, were not particularly 
problematical. In such cases rabbit peritoneal cells 
could bo used and were available in large numbers. 
However the application of the technique to clinical 
situations in humans was somewhat difficult. In 
cases where the subject of chemotactic investigation 
was neutropenic or in circumstances which do net 
permit the withdrawal of large volumes of blood 
the technique was rather ljmited.
Subsequent modificacions by various workers have 
reduced the size of the upper and lower chambers and 
the surface area of the millipore filter. Such 
modifications have been reported by Ward ct al3 
(1966), Kay (1970), Miller (1971) Wilkinson (1971b), 
and Martin et cil, (1973) and have permitted reduced 
cell number requirement and reduced leucoattractant 
volume. In most clinical investigations such 
modified chambers are now used.
Modifications associated with cell enumeration
1) Keller et at, (1971) demonstrated that 
cell loss from the lower side of the chemotaxis 
filter can and does occur. Such loss increases with 
time. To avoid 'cell-droppage' these authors
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suggested a double filter system. Loss of cells was 
prevented by collecting PMN cells on a cell- 
impermeable filter, placed underneath the cell- 
permeable filter. The chemotactic index was 
assessed by enumerating the cell number on the lower 
side of the upper filter and on the upper side of 
the lower filter. The two figures were summed to 
give the chemotactic index. In this laboratory, 
however, all droppage from the filter after 3 hours 
of incubation has been shown to be insignificant as 
assessed by Coulter counting of cells present in 
the lower compartment. Furthermore, cell distribution 
on the lower filter was extremely variable and cell 
presence may only reflect those areas in which the 
filters were in opposition.
2) Gallin et al, (1973) reported an "improved"
in vitro millipore technique for the evaluation of 
chemotaxis. Using this method PMN cells were radio- 
labelled with Chromium-51 prior to introduction into 
the cellular compartment of a modified Boyden chamber. 
A double millipore filter system as described above 
was used, with the exception that both filters were 
of 5y pore diameter. The system was incubated 
for 3 hours after which time the filters were 
separated and the radioactivity associated with 
each filter was determined. Chemotaxis was assessed 
by the amount of radioactivity associated
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with the lower filter.
This technique has certain advantages 
such as the elimination of staining procedures 
and removal of observer error. However the 
same criticisms mentioned above for the double 
filter systems may apply to this system also.
This technique does not permit assessment of 
intra-filter events in the early stages of cell 
movement.
3) Zigmond and Hirsch (1973) presented a 
modified micropore filter technique designed to 
facilitate the microscopic evaluation of chemo- 
taxis. Test solutions being investigated for 
chemotactic potential v?ere placed in the lower 
chamber and cell suspension in the upper chamber.
A negative control of a non-chemotactic solution 
was run in parallel. The chamber incubation 
period was shortened to allow cellular migration 
into the filter but not complete filter trans­
passage by the cells. After a suitable time 
interval filters were removed, stained and 
cleared as previously. However, as with previous 
techniques the filter was not inverted and the 
lower side quantitated, but was scored by measur­
ing with the optical micrometer on the fine focus 
knob of the microscope, the distance from the top 
of the filter to the furthest focal point which 
contained at least two cells in focus. In positive
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controls the distance migrated into the filter 
by the "fastest moving cell front" was much 
greater than that of the negative controls.
With this technique, results are expressed in 
microns travelled and not cells per high power 
field.
With regard te investigations of leucotactic 
dysfunction, the technique of Zigmond and Hirsch 
may have certain limitations. Using this method 
cellular quantitation may be difficult since a 
number of cells may migrate into the filter to 
normal depths, thus masking the inability of 
others to elicit a chemotactic response. The 
method of Zigmond and Hirsch could be used to 
assess the quality of the neutroj: il response ar 1 
that of Hoyden used quantitatively. This may be an 
invalid criticism.
Using this technique, Zigmond and Hirsch (1973) 
have shown that chemoattractants may exert a two­
fold effect on neutrophil motility. Leucoattractants 
in the absence of a gradient (equal concentrations 
above and below the filter) promote an enhancement 
of random migration. Guch a stimulation of random 
motility has been termed chemokinesis (Wilkinson,
1975). The extent of chemokinesis is dependent on 
the concentration of leucoattractant usually 
increasing with increasing leucoattractant concentra­
tions. However, at high chemoattractant concentrations,
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chemokinesis may diminish, presum.' ly due to 
de-activation. By determining chemokinesis 
values for a given range of concentrations of 
a leucoattractant substance it is possible to 
evaluate the distance migrated on a directional 
basis. This can be achieved by calculation of 
the predicted distance of migration for a given 
positive gradient, assuming migration to be on a 
random basis, from chemokinesis values observed 
with leucoattractant concentrations at either 
limit of the positive gradient and intermediary 
(Zigmond and Hirsch, 1973). The distance migrated 
on a truly directional basis, true chemotaxis, 
is obtained by subtraction of the predicted 
value (based on chemokinesis) from the observed 
value for the positive gradient. Positive vali^s 
indicate a true chemoLactic response. This 
method can be used to evaluate cell capacity 
to elicit a directional response to a known chemo- 
tactic factor. Conversely, the leucotactic 
potential of a given substance can be investigated.
Up to this point the term chemotaxis, implying 
a "one-step" directional movement, has been used 
frequently and possibly incorrectly. It is therefore 
pertinent to mention that the report of Zigmond 
and Hirsch (1973) has demonstrated that chemo­
attractants may influence leucocyte motility in two 
ways. Apart from a true directional cellular 
response to a positive concentration gradient
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the leucoattractants, in the absence of a 
gradient, may also promote increased random 
motility. This type of-, cell movement is 
termed chemokinesis. The process of leuco­
cyte accumulation by artificial induction either 
in vivo or in vitro is therefore not a single 
step procedure, but rather an additive effect 
of chemokinesis and chemotaxis. This would 
appear to be a biologically sound combination. 
Chemotaxis should hasten the arrival of cells 
at an inflammatory site while the sti. ilated 
random component may facilitate the circum­
vention of any mechanical barriers encountered 
en route and enhance collision with offending 
particles at the destination point.
Modifications associated with cell application
Baum et al} (1971) and Hill et al, (1975b)
have reported that the cytocentrifuge can be 
used to apply neutrophils directly to micropore 
filters. This eliminates abnormal or unequal 
settling of cells. However, time and speed of 
centrifugation are critical to achieve a regular 
distribution on the membrane surface. The 
author has no personal experience of this 
technique.
P A R T II
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METHODS IN CHEMOTAXIS
1) The Chemotaxis Chamber
Due to uneconomical cell and serum requirements 
the Boyden technique was considered unsatisfactory.
It was therefore decided to adopt a micro-chemotectic 
technique.
The technique chosen was that introduced by 
Wilkinson (1971). The chamber used in chemotaxis 
tests was a simplified version of Boyden's original chamber 
The lower compartment was a 5 ml. glass beaker. This was 
filled with 4 ml. of the chemotactic substance under test. 
The "sawn-off" barrel of a tuberculin syringe was suspended 
in this fluid, and a circular filter was glued to its lower 
end. The type of glue used was commercially available, of 
the trade name of "Uhu". This glue satisfied 3 criteria 
(Wilkinson, personal communication, 1973):
a) It was non-toxic to PMN cells.
b) It was non-chemotactic.
c) It was methanol soluble.
Chamber modifications
A number of modifications were introduced +-o 
Wilkinson's method.
a) Alterations to the cell compartment
To facilitate filling of the inner chamber the "barrel 
length" was reduced to 6 mm to allow the "layering" of cell
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suspension onto the millipore filter. This modification 
was slightly more economical on materials as 2 chambers 
per syringe could be made.
b) Alterations of fluid compartment
In place of a 5 ml. beaker in which 3 cell chambers 
were suspended, individual chambers were made. A 5 ml. 
plastic test tube "push-on" cap was punched with a 
number 2 cork-borer, and the circular plastic disc removed. 
The "cell-chamber" (syringe and filter) was fitted into 
this and was tightly held in place, while permitting 
vertical adjustment. A 4 ml. autoanalyser tube substituted 
for the beaker to give a system consisting of one ceil 
chamber/one fluid chamber. The inner chamber freely fitted 
the outer chamber. This modification permitted ease of 
manipulation of the inner chamber to equalize inner and 
outer fluid levels during chamber assembly. Facilitated 
manipulation of the inner chamber during cell fixation was 
also allowed.
c) Elimination of air bubbles
A major problem with this technique was the appearance 
of air bubbles, above and below the filter during chamber 
filling. This may be caused by air trapped within rhe 
filter. This problem was eliminated by pre-«filling of the 
chamber with cell suspending solution. Chambers were 
allowed to stand for a few minutes, during which time ai^ 
bubble formation occurred, then emptied and filled with
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leucoattractant and cell suspension. No air bubbles 
formed within the experimentally assembled chambers. 
This modification, although slightly more time 
consuming, permitted closer filter-filter agreement.
A diagram of the modified chamber is presented 
in Figure la (See below):
Diagram of the 
chamber.
Figure la modified chemotaxis
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2) Neutrophil Preparation
Heparinized human venous blood (5 units preserva­
tive free heparin, Pan Heparin, per ml. of blood) was 
centrifuged at 500 g for 10 minutes. The buffy layer 
cells present at the white-red cell interface ar.d the 
first few millimetres of the red cell layer were trans­
ferred ro plastic test tubes. This leucocyte-rich 
supernatant was sedimented at 37°C for 30 minutes to 
further remove red blood cells (RBC). After sedimenta­
tion the leuc.ocyte-rich plasma was removed and diluted 
in equal parts with tissue culture medium (TC 199 
Grand Island, New York) pH 7.2 and centrifuged for 5 
minutes. The supernatant was removed and tne cell 
pellet resuspended and washed twice with TC 199 (500 
g for 5 minutes). The cell suspension was adjusted to 
give an appropriate concentration which was determined 
by the nature of the leucoattractant or volumes of 
various drugs added to the cell suspension.
3) Leucoattractant Preparation
Two leucoattractants have been used in this study, 
a) Alkali Hydrolysed Casein
Casein was solubilized according to the method of 
Wilkinson (1972). Commercially available casein 
"Hammarsten" (Merck) was insoluble in TC 199 at pH 7.2. 
However, by gently increasing the pH, by drop-wise 
addition of 1M NaOH, to pH 12, casein solubilized.
The solution was carefully brought back to neutrality 
with Nal^PO^.2H2O. The final concentration or casein 
was 5 mg/ml. TC 199. The casein solution was then 
titrated to determine the dilution which induced 
optimal neutrophil cherr.otaxis, For all studies in 
this presentation the same casein preparation was 
used at an optimal concentration of 600 yg/rnl.
b) Endotoxin activated serum (EAS):
This was prepared by the interaction of fresh, 
normal human serum with a purified endotoxin prepara­
tion. Purified bacterial endotoxin was obtained 
commercially as Difco Lipopolysaccharide (E.coli 0127 : 
B8). The endotoxin was carefully weighed out prior to 
each experiment and chemotactic activity generated by 
the addition of fresh serum (500 yg endotoxin/ml. 
serum). The mixture was incubated at 37°C for 30
minutes to generate chemotactic activity and diluted 
\ by the addition of 3 parts of TC 199. The concentra­
tion of EAS in this system which induces optimal 
neutrophil chemotaxis is 25% (Anderson, 1974).
4) Chemotaxis Assay
Two cypes of assay were employed:
a) The Boyden assay
Assembly and Incubation of Chambers. The chemotactic 
chamber used for both assays is based upon the modifica­
tions introduced by Wilkinson (1971)i of the Boyden
chamber. In the classical Boyden system leucoattractanr 
substances (1 ml. volumes) were introduced to the lower 
chamber. Numerically standardized neutrophil suspensions 
were introduced into the upper chamber with a long- 
needled 1 ml. syringe. A cell volume of 0.2 ml. was 
carefully layered onto the millipore membranes of pore 
size 5 y (Millipore Corp). Chambers were always pre­
incubated with cell suspending medium alone, to 
permit formation and elimination of air bubbles. The 
chambers were emptied of medium,and cell suspensions 
and leucoattractants introduced to their resj- active 
compartments. The inner chamber (cells) was then 
fitted into the lower chamber (leucoattractant) and 
the inner and outer fluid levels equalised. Chambers 
were incubated at 37°C for three hours, with the 
exception of kinetic experiments (1-5 hours).
Filter removal and staining. Subsequent to incubation 
the inner chamber was carefully removed and immersed 
in methanol for 30 seconds. Methanol caused cell 
fixaticn and also dissolved the glue. The filter was 
easily removed. Filters were rinsed in distilled 
water and stained in haematoxylin for 1 minute. After 
staining, filters were rinsed in distilled water.
The subsequent stages were 1 minute in each of:
1. 75% ethanol.
2. 90% ethanol,
3. 80 : 20 ethanol: butanol.
4. 100% ethanol.
5. Xylene.
The first four stages are dehydrating steps, 
while the final stage causes filter clearing.
Microscopic evaluation of chemotaxis. Following 
staining, the filters are inverted (so that the 
bottom side is uppermost), placed on a glass slide, 
and mounted in xylene. Chemotaxis is assessed under 
the high power, by counting the number of cells 
which have completely traversed the filter. Count­
ing is greatly facilitated by the use of an optical 
grid. The chemotactic index is expressed a: cells 
(neutrophils)/ high power field (HPF). Using this 
technique the mean filter-filter variation is 17.2% 
for identical filters.
b) The Method of Zigmond and Hirsch
The modificatiOiis of the method of Boyden (1962) 
as introduced by Zigmond and Hirsch (1973) have been 
described in Chapter III (Page 41). These relate to 
manipulations of leucoattractant concentrations in the 
cell and chemoattractant chambers to discern types of 
motility, i.e. chemokinesis and directional migration; 
a shortened incubation period which also does not 
permit trans-filter passage of cells; and an evaluation 
of cell motility according to the intra-filter distance 
attained by the "fastest moving cell front". Chamber 
assembly and filter staining and processing procedures 
are identical to those used in Boyden's method.
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Experimental Design. To determine the ■ fects of 
a potential leucoattractant substance on chemo- 
kinesis and chemotaxis, dissociation of these two 
types of motility is necessary. This can be 
accomplished by the method of Zigmond and Hirsch 
using the experimental system referred to as 
"the checkerboard" (Wilkinson, 1975 - personal 
communication). The experimental design is shown 
in Table 1.
TABLE I
Experimental Design, with results 
of a hypothetical Checkerboard
Leucoattractant Concentratic (% EAS) 
Below the filter
3 6 12
Results are expressed as microns migrated (pm). 
Figures within the diagonal lines are experimentally
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derived values for chemokinesis (equal concentra­
tions of leucoattractant (EAS), above and below the 
filter). Those above the diagonals, outside the 
brackets, are experimental migratory values in 
positive gradients (higher concentrations of EAS 
below the filter). Results in parenthesis are 
expected values for migration in positive gradients 
(assuming migration to be on a solely random basis) 
calculated by the method of Zigmond and Hirsch (1973). 
The extent of directional migration is calculated by 
subtraction of the expected value from the observed 
(experimental) value. Results below the diagonal 
(not shown) represent migratory values in negative 
gradients (higher concentrations of leucoattractant 
above the filter).
Calculation of predicted migratory values in 
positive gradients, using the method of Zigmond 
and Hirsch, from results shown in Table i.
There are three positive gradients shown in 
Table 1.
Positive gradients shown in 
Table 1
% EAS above % EAS below
filter filter
A 3 6
B 3 12
C 6 12
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Predicted value for Gradient A
Assumptions which have to be made (Zigmond 
and Hirsch, 1973)are:
1) A linear gradient extends across 
the filter.
2) Acceleration of cells between two 
known velocities is constant,
3) Movement of the front two cells of 
the .population can be considered as 
a single particle moving with a 
velocity which is a function of the 
concentration of stimulatory 
material.
Known values
Depth of filter =
Time of incubation (T) =
Velocity in 3% EAS (V^ =
Velocity in 6% EAS (V2) =
Velocity in 12% EAS (V3) =
Calculation
120 y
40.minutes .(1 unit time) 
55 ym 
70 ym 
65 urn
For this gradient, (3%/6% EAS) the distance moved 
will be the sum of the distance migrated in 3% EAS 
(5ym) plus the increment due to acceleration from 3% EAS 
— } 6% EAS.
.’. Distance travelled
in 1 unit time = 55 ym + extra distance
due to acceleration (ym)
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Extra distance migrated 
due to acceleration from
3% —-> 6% EAS in 1 unit ■
rime = V2 " V1
= 70 - 55 pm/unit time
= 15 pm/unit time
.’. over 55 pm the extra 
distance migrated due to 
acceleration = 15 x 55 pm
=
120 
6.46 pm
.'. total distance 
travelled in 1 unit/time 
from 3% — > 6% EAS 61.46 pm
Calculation of predicted value for Gradient B
This calculation is more complicated since 
3 chemokinesis values must be taken into consideration. 
Distances migrated in 3% EAS = 55 pm, 6% EAS = 70 pm, 
12% EAS - 65 pm; d^ (the distance from the top of the 
filter to the place in the filter where the concentra­
tion is 6%) will be one third of the way through the 
filter (40 pm) since a linear gradient has been 
assumed. The remaining distance d  ^ (80 pm), represents 
the distance of the 6% —  ^12% EAS gradient.
5 7
Known values
dl II O ym
d2 = 80 ym
V1 = 55 ym/unit time
V2
0r-~li ym/unit time
v. II CTi U1 ym/unit time
Required:- To calculate the total distance migrated 
rrom 3% -> 12% EAS in 1 unit time.
The total distance 
migrated = The distance migrated from 
3% — 7- 6% EAS + extra distance 
migrated from 6% — ■t- 12% EAS 
in the time remaining.
= dj + dx pm
= 40 + dx pm
r p  - taken to m  *? r r v n
from 3% — } 6% EAS (T^
.". Time remaining (T2)
dx
'2_
40
62.5
0.610
1 - 0.610 
0.390 
(V2) <T2)
unit time
unit time 
unit time
unit time
+ increment due to 
acceleration in T2
5 8  .
Distance migrated due to 
acceleration in 1 unit
time = ' V3 - V2 ym
= -5 ym/unit time
d„ = 80 pm
. ’ . Distance migrated due 
tc acceleration from 6% ->
12% EAS
ax
= --5 x 80/unit time
120
= -3.33 ym/unit time
- 70 ym/u^it Lime (0.390 unit
time + (-3.33 ym/unit time) (0.390 
unit time).
= 27,3 ym - 1.3 ym
- 26 ym
. *. total distance 
migrated = 4 0 + 2 6  ym
= 6 6 ym
This calculation is a slightly simplified version 
of the method of Zigmond and Hirsch (1973) but final 
results are identical.
Calculation of predicted value for Gradient C
This calculation is identical to that for 
Gradient A with substitution of the appropriate values.
Calculation of true chemotactic increments
This is accomplished by subtraction of the 
predicted value as calculated above and from the 
observed value. The true chemotactic increment 
for migration from 3% — -> 6% EAS is 78 pm - 61 ;im 
= 17 pm. Similarly the respective values for 
3% — ■> 12% and 6% — >■ 12% EAS are 26 pm and 14 pm.
Using this system it is possible to assess the 
potency of a leucoattractant and the precise 
effects of inhibitors and stimulants of cell motility 
on random and directed locomotion. Using this 
technique variation between identical experimental 
filters is slight (8.8% mean variation).
Assessment of neutrophil random migration
Random migration was assessed in Boyden chambers 
using the methods of Boyden and Zigmond and Hirsch.
No leucoattractants were present in this system. 
Medium 199 was present above and below the filter.
The medium was supplemented with 0.1% bovine serum 
albumin to enable adequate neutrophil migration 
(Becker and Ward, 1969). Filter processing 
and counting procedures were identical to those for 
chemotaxis.
i
Intracellular cyclic nucleotide estimations
Neutrophil preparation. Human peripheral blood was 
collected as previously described and separated on a
Ficoll Hypaque gradient by centrifugation at 600 g 
for 15 minutes. Mononuclear cells were di carded and 
the resultant pellet resuspended in physiological 
saline and sedimented at 37°C for 30 minutes with a 
25% volume of 3% gelatin (Difco, Detroit, Michigan). 
Celatin is a biologically inert protein and was used 
in preference to high molecular weight dextrans which 
stimulate neutrophil phagocytic activity (Sher et al, 
1374). The neutrophil-rich fraction was removed and 
centrifuged at 250 g for 10 minutes and the resultant 
cell pellet treated with 0.83% ammonium chloride at 
4°C for 10 minutes to lyse residual erythrocytes.
The latter procedure has no effect on neutrophil 
function (as assessed by effects on migration). 
However, centrifugation at 600 g for 30 - 40 minutes 
in Ficoll-Hypaque markedly reduces chemotactic 
responsiveness. No such effects were observed when 
the time of centrifugation was reduced to 15 minutes. 
These procedures have been adopted to minimize non- 
experimental alterations in cell function.
Experimental system. Subsequent to lysis the 
remaining cells, which consistently contained 05 - 
99% viable neutrophils were washed once and
7resuspended to 2 x 10 neutrophils/ml. Cell suspen­
sions (0.5 ml.) were treated with appropriate 
concentrations of the materials under investigation
7to give a final concentration of 10 neutrophils/ml.
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After varying incubation times (0, 1, 3, 5, 10, 20 
40 and 60 minutes) the reaction was terminated by 
the addition of an equal volume of cold 2% 
perchloric acid (PCA). Neutrophils in each tube 
were further disrupted in an MSE ultrasonic 
disintegrator for 2\ minutes at an amplitude of 
30 peak to peak. The specimens were then centri­
fuged at 500 g for 10 minutes, the pellet 
discarded and the supernatant restored to pH 7.0 by 
the addition of 0.3N KOH. Specimens were re­
centrifuged for 20 minutes, and were then freeze- 
dried on a Vertis lyophiliser.
Radioimmunoassay procedures. Freeze-dried specimens 
were reconstituted in 0.05M sodium acetate buffer, 
pH 6.2, and aliquots of 0.2 ml. were used for cGMP 
and 0.1 ml, for cyclic AMP estimations. The Schwarz/ 
Mann cyclic AMP and GMP radioimmunoassay kits and 
the procedures supplied with each kit were used. 
Standard curves were run with each assay and were 
found to be consistently linear. Duplicate samples 
were assayed and the final results expressed as pico
7(p) moles/10 PMN (polymorphonuclear leucocytes).
The assay procedures for both cAMP and cGMP
involve the competitive binding of the succinyl
125cAMP/cGMP tyrosine methyl ester (I labelled 
standard provided) and endogenous cyclic nucleotide 
for a limited number of binding sites on an antibody 
specific for cAMP or cGMP. Aliquots of the specimen
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(0.2 ml. for cGMP and 0.1 ml, for cAMP) are 
incubated with 0.1 ml. of antibody and 0.1 ml, of 
radiolaioelled antigen. The final reaction volume 
is 0.5 ml. Tests are incubated for 18-24 hours 
at 4°C. After incubation, a 2,5 ml. volume of 
60% saturated ammonium sulphate j(NH^ ) ^ SO^ j is 
added to each tube which is allowed to stand at 
4°C for 10 minutes (protein precipitation), The 
resultant precipitate is centrifuged at 5 000 g 
for 20 minutes and the supernatant discarded.
The radioactivity associated with the protein 
precipitate is measured by solid crystal scintilla­
tion counting for 1 minute.
The concentration of cyclic nucleotide in the 
unknown is inversely proportional to the amount of 
radioactivity in the precipitate. Cyclic AMP and 
cyclic GMP in the specimen compete with the corres­
ponding radiolabelled standard cyclic nucleotide 
for the appropriate antibody. The greater the 
concentration of the antigen in the sample the less 
radiolabelled standard will bind with the antibody. 
The (NH^^SO^ precipitates the antigen/antiboay 
complexes, but not rhe non-protein antigen and the
degree of radioactivity in the precipitate reflects
125the amount of standard (I ) antigen which has been
bound.
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Calculation of results. For cAMP the known 
concentrations used for construction of the stan­
dard curve are 0.025, 0.050, 0.10, 0.25, 0.50,
1.0, 2.5, 5 and 10 p moles. The known concentra­
tions for the cGMP standard curve are 0.1, 0.2,
0.5, 1.0, 2.0, 4.0 and 10 p moles. Calculation 
is as follows:
1) Duplicate background counts are averaged and 
subtracted from average duplicate values for each 
•cyclic nucleotide concentration to give the 
corrected standard counts.
2) The standard counts arc converted to a percent
of the corrected trace binding counts. Trace
binding samples are those containina radiolabelled
cyclic nucleotide and antibody only (no unlabelled
antigen present) and should represent the maximum
125amount of antigen (I ) which can be bound. The 
concentration of unlabelled cAMP or cGMP is 
inversely proportional to the % trace binding.
i.e. % of trace binding Standard Count x iqO
Trace Binding Count
For cAMP the results are plotted as % trace 
binding against p mole/tube on semi-log paper with 
p mole/tube as the log function. For cGMP the 
results of the standard curve are plotted on logit- 
log paper with % trace binding as the logit function 
against p mole cGMP:tube as the log function.
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For each experimental series the same batch 
of radioimmunoassay kits was used. Standard 
curves were always included whenever a radioimmuno­
assay was performed and results calculated from 
the standard curve. The profiles of the standard 
curves always confirmed to the specifications of 
the manufacturer. Standard curves for cAMP were 
linear for the concentration range 0.2 - 5.0 p moles. 
Those for cGMP were linear for the complete concentra­
tion range (0.1 - 10 p moles). Variation between 
duplicate counts was small and those wirh a difference 
of more than 10% were omitted.
Typical standard curves for cAMP and cGMP (from 
this investigation) are shown in Figures lb and lc 
respectively.
Assay of Glycolytic activity. The extent of glyco­
lysis was measured by lactate production (Hohorst,
1962) using recognized procedures (Boehinger iMannheim, 
Biochemical Test Combination). Pure neutrophil 
suspensions (prepared as for cyclic nucleotide 
estimations) were used in this study and resuspended 
to a final concentration of 2 x 10^/ml. in 0.15M 
phosphate buffered saline (PBS) containing lOmM glucose. 
Each assay tube (performed in triplicate) utilized 
6 x 106 PMN (0.3 ml.) in a final volume of 0.5 ml.
The remaining 0.2 ml. contained the various agents 
(leucoattractants or drugs) under investigation.
Tubes were incubated at 37°C for various times in
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Figure lb Typical standard curve for the estimation
of cyclic AMP.
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Figure lc Typical standard curve for the estimation 
of cyclic GMP,
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kinetic experiments (0-60 minutes) or for a 
fixed time (60 minutes). Following incubation 
the reaction was terminated and the system de- 
proteinized by the addition of 1.0 ml. of cold 
0.6N PCA. Tubes were mixed well and centrifuged 
at 3_,000 rpm for 10 minutes. Aliquots (0.2 ml.) 
from each tube were assayed for lactic acid.
The principle of the assay is the spectro-
f
photometric change accompanying the reduction of 
the enzyme cofactor B - nicotinamide ade.. me di­
nucleotide (NAD+) to NADH during conversion of 
lactate to pyruvate by lactic dehydrogenase (LDH). 
Each assay tube contains the following:
1. 2.00 ml. of assay buffer (0.5M 
glycine buffer pH 9.0; 0.4M hydra­
zine).
2. 0.20 ml. of 27mM NAD. '
3. 0.02 ml. of LDH (2 mg LDH/ml,)
4. 0.2 ml. of supernatant fluid 
after deproteinization.
For blanks 0.20 ml. of 0.6N PCA substitutes 
for supernatant fluid. Tubes are incubated at 25°C 
for 60 minutes and the change in optical density at 
340nm (AE340nm) is assessed spectrophotometrically.
gResults are expressed as mg.lactate/6 x 10 PMN/ 
unit time, by the conversion factor 0.25 x AE340 = 
mg ]actate/0.5 ml.
The variability between identical samples was 
3.1%.
Assay of Hexose Monophosphate Shunt (h m p) Activity
The extent of HMP activity was measured
according to the method of Wood et al3 (1963) by
14potassium hydroxide (KOH) absorbtion of C
1^produced from glucose radiolabelled (C *) in the
C1 position. (Obtained from New England Nuclear,
14Boston, Massachusetts as D-Glucose 1- C). lure 
neutrophil suspensions were used for this s-t-udy 
and resuspended to a final concentration of 
2 x 10^/ml, in glucose free 0.15M PBS. Each 
assay was performed in duplicate and utilized 
4 x 10^ PMN in 0.2 ml. and 0.6 ml. of glucose in 
PBS containing 0.06 yCi. The remaining 0.2 ml. 
contained the various agents (leucoatcractants 
or drugs) under investigation..
The test apparatus was a 20 ml. glass 
scintillation vial (Packard) which served as the 
outer chamber stoppered with a tightly fitting 
perforated McCartney top. Placed inside the 
outer chamber was a 2 ml. autoanalyser C u ?  which 
served as the inner chamber. The radiolabelled 
glucose was placed in the outer chamber and 
0.6 ml. of IN KOH in the inner chamber. The outer 
chamber was stoppered and the apparatus allowed to 
stand in a 37°C water bath for a few minutes.
The reaction was initiated by the introduction of
the cell suspension to the cuter chamber by
injection through the cap with a long-needled
syringe. For kinetic experiments the time range
used was from 0-60 minutes; the reaction was
terminated by the addition of 2 ml. of 2N HC1
to the outer chamber through the cap with a
long-needled syringe. The chambers were allowed
to stand for 60 minutes to permit release of 
14C 02 and absorbtion by the KOI!, 0.5 ml.
volumes of KCH were then transferred to scintil­
lation vials containing 10 ml. of acid instagel 
(5.5 ml. of 17N HCl/litre instagel (Packard) 
and speciments counted on a Tri-Carb liquid 
scintillator for 5 minutes. Results were 
expressed as corrected mean counts per minute 
(cpm). Background controls contained radio- 
labelled glucose and appropriate additives, except 
neutrophils, and counts obtained were subtracted 
from the corresponding experimental values. The 
variability between identical samples for this 
technique is 7.1%.
Semi-quantitative Nitroblue Tetrazolium Test (N.B.T.)
This test was performed according to the 
method of Sher et al, (1974). Pure neutrophils
(0.2 ml. of a suspension containing 3 x 10 
PMN/ml.) were mixed with equal volumes of
N.B.T. solution (i mg/ml.) and the appropriate 
stimulant. Tubes were incubated at 37°C for 
30 minutes and smears of the mixtures were 
made on glass slides after incubation. These 
were fixed in methanol and stained for 5 
minutes in dilute 10% haematoxylin. Slides 
were evaluated microscopically and results 
expressed as percentage cf N.B.T. (reduced) 
positive PMN.
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C H A P T E R  V
The Effects of Exogenous
Cyclic Nucleotides on Neutrophil Motility
In Vitro
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INTRODUCTION
The effects of exogenous cAMP on various types of 
neutrophil motility has been evaluated by a number of 
research groups using the classical Boyden system.
Reports pertaining to the leucoattractant potential of 
cAMP have been conflicting, although there seems to be 
agreement in the few reports available that exogenous 
cAMP mediates an inhibtion of neutrophil chemotaxis.
However, effects on random migration are variable. A 
major criticism of these studies is that the t< "hniques 
used by these groups do not permit an accurate analysis 
of the effects on neutrophil locomotion since there is 
no dissociation of random from directed motility in 
positive gradients. Zigmond and Hirsch (1973) have 
stressed the necessity of distinguishing whether altered 
locomotory responses to a given factor are attributable 
to either or both of directed and random motility.
Cyclic GMP has been reported by Estensen et at, (1973) and 
Hill et al, (1975), in different reports from the same 
laboratory, to enhance neutrophil chemotaxis, but effects 
on random migration were not described. The aforementioned 
criticism is also applicable to these reports.
The present study has been motivated by the uncertainty 
of cyclic nucleotide effects on neutrophil motility; cAMP, 
d'cAMP and cGMP have been investigated using the classical 
Boyden technique and the method of Zigmond and Hirsch.
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MATERIALS AND METHODS
a) Chemicals
Adenosine 3' : 5' - cyclic monophosphoric acid
6 2(cAMP) as the sodium salt and ir, 0 - dibutyryl
adenosine 3' : 5' - cyclic monophosphoric (d'cAMP) as 
the moncsodium salt were obtained from the Sigma 
Chemical Company (St. Louis, Missouri) and were of 
98% and 97% purity respectively. Guanosine - 
3' : 5' - cyclic monophosphoric acid of 98% purity 
(consistently unavailable from Sigma Chemicals) was 
supplied by Boehringer Mannheim, South Africa,
Neutrophil preparation: Neutrophils were obtained from 
20 ml. of heparinized whole blood (5 units heparin/ml.) 
donated by healthy male and female labors'ory workers. 
After sedimentation at 37°C the buffy layer was processed 
as previously described (Chapter IV, page 49).
Leucoattractants: Two chemotactic agents were used in
this study.
a) Fresh serum activated by 500 g/ml. of bacterial 
lipopolysaccharide (E.coli 0127 : B8 Difco) (EAS).
The mixture was incubated for 30 minutes at 37°C followed 
by a fourfold dilution with TC 199.
b) Denatured casein at a final concentration of
600^g/ml. prepared by alkali hydrolysis with subsequent 
readjustment to pH 7.2. The final cell concentration was
g3 x 10 PMN/ml. when EAS was used as leucoattractant and 
5 x 106 PMN/ml. when casein was used, the latter being the
weaker of the two chemoattractants.
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Cell motility studies
Two types of assay were used in these studies.
1) The Boyden assay was used in a first series of 
experiments to assess the leucotactic potential of cAMP 
and cGMP. In this study neutrophils were suspended to 
a final concentration of 5 x 10^/ml. in TC 199 
supplemented with 0.1% bovine serum albumin (BSA).
Cyclic AMP and cyclic GMP were dissolved in the same
-7medium to give a final concentration range of 1 x 10 M - 
-35 x 10 M. Protein was added to the TC 199 since the 
reaction system was protein free and it has been reported 
bv Keller (1966), that protein supplementation is 
necessary for adequate migration. Cell suspensions 
(0.2 ml.) were placed in the upper chamber and cyclic 
nucleotides (1 ml.) in the lower chamber. Chambers were 
incubated for 3 hours at 37°C. Following incubation, 
filters were removed, fixed, stained, dehydrated and 
cleared- Results are expressed as cells/HPF on the lower 
surface of the filter.
In the second series of experiments the effects of 
cAMP, d 'cAMP and cGMP on neutrophil random migration and 
chemotaxis to EAS and casein were investigated. Neutro­
phils were preincubated with the cyclic nucleotides 
-7 -3( 1 x 1 0  M - 5 x 10 M) for twenty minutes prior to 
introduction to chemotactic chambers. The cells remained 
in contact with the drugs throughout the incubation period. 
Final cell concentrations were 3 x 10^ PMN/ml for EAS
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studies and 5 x 10^/ml. for random migration and casein 
chemotaxis. TC 199 was supplemented with 0.1% EAS for 
random migration studies but not for chemotaxis. Chambers 
were incubated for 3 hours followed by filter processing 
and counting.
2} The method of Zigmond and Hirsch was also used to 
assess the leucotactic potential of cAMP and cGMP, The 
reaction systems were identical to those employing the 
Boyden technique, the exception being the time of incuba­
tion which was reduced to 40 minutes. To investigate the 
effects of the cyclic nucleotides on chemotaxis, two 
fixed positive gradients were selected. Both systems 
employed 3% EAS above the filter and 6% and 12% EAS for 
respective systems below the filter. For chemokinesis a 
fixed identical concentration of EAS on both sides of the 
filter was selected (3% EAS). In these studies, neutro­
phils were treated with the cyclic nucleotides for a 
twenty-minute preincubation period and throughout chamber 
incubation. EAS was added to the neutrophil-cyclic 
nucleotide mixture following preincubation to eliminate 
deactivation as a possible complicating factor,
For reaction systems in which an effect on either 
chemokinesis or chemotaxis was observed a checkerboard 
(Chapter IV, page 53) was performed to distinguish the 
precise types of motility affected. The checkerboard 
was constructed according to the method of Zigmond and 
Hirsch (1973). Varying concentrations of EAS (1.5%, 3%,
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6%, 12%) were placed above and below the filter in all 
possible combinations. Chambers were incubated for 
40 minutes at 37°C, processed and mounted with the top 
side uppermost. Neutrophil migration was expressed as 
the distance travelled (ym) as measured with the 
optical micrometer on the fine focus of the microscope.
RESULTS
heucotactic potential of cyclic nucleotides
The results of experiments in which cAMP and cGMP 
were employed at varying concentrations in the leuco- 
attractant chamber in both assay systems are shown in 
Table 2 (page 77) and Table 3 (page 78). Results are 
expressed as mean values for 6 experiments with standard 
deviations. For all concentrations employed of cAMP 
and cGMP in both assay systems no significant differences 
from control values were evident (Student test).
EFFECT OF cAMP, d 'cAMP AND cGMP ON RANDOM MIGRATION AND
CHEMOTAXIS TO EAS AND CASEIN
The effects of cAMP and cGMP on neutrophil random 
migration and chemotaxis to both leucoattractants in the 
Boyden system, and on chemotaxis and chemokinesis as 
assessed by the method of Zigmond and Hirsch are shown in 
Table 4 (page 79) and Table 5 (page 80) respectively. 
Results are expressed as mean values and standard deviations 
for 6 experiments. For all cAMP and cGMP concentrations in
random and directed motility studies utilizing both
assay systems no significant differences from control
values were evident. Dibutyryl cAMP appeared to have
no effect on chemotaxis in both assay systems, (Table 5,
page 81) however, a statistically significant stimulation
-4 -3of random migration (5 x 10 M - 2,5 x 10 M) and cheiro-
-4 -3kinesis (5 x 10 M - 5 x 10 M) was evident. To ascertain
the precise effects of d 'cAMP on neutrophil motility a
checkerboard was performed in the presence and absence of 
-310 M d 'cAMP. This concentration was employed since it 
mediates maximal stimulation of random migration and 
chemokinesis (p = ^ 0.001). The results of the experiments 
utilizing different combinations of EAS above and below 
the filter are shown in Table 7. It is evident that 
stimulation of cell movement in the presence of d 'cAMP 
occurs in the absence of a gradient (within the diagonal) 
and for negative gradients (below the diagonal), but
nut for positive gj_adreiits, iese results indicate that
d 'cAMP produces stimulation of both random migration 
(35%) and chemokinesis (22%, 39%, 51% and 75% for 1.5%,
3%, 6% and 12% EAS above and below the filter respectively)
To evaluate the effects of d 'cAMP on directed motility 
the true increments for corresponding gradients, in the 
presence and absence of d 'cAMP, were compared. The true 
increment was taken as the difference between the observed 
values for positive gradients and the estimated values (in 
brackets) based on chemokinesis according to the formula 
of Zigmond and Hirsch (1973). These results are shown in
TABLE 2
Analysis 
a) The
-7 -3of the Leucotactic Potential of Cyclic AMP (10 M - 5 x 10 M) using 
Method of Boyden and b) The modification of Zigmond and Hirsch
Concentration of 
Cyclic AMP
Cells HPF/3 hours 
Mean and Standard Deviation
Intra-filter penetration/ujn/4 0 minutes 
Mean and Standard Deviation
1 x 10_7M 
1 x 10“6M 
1 x 10-5M 
1 x 10“4M 
1 x 10“3M 
1 x 10_3M 
1 x 1C"3M
25 + 5.7
24 + 6.8
28 + 7.5
25 + 6.6 
25 + 6.8
29 + 8.7 
24 + 2.8 
22 + 1.5
47 + 7.0
46 + 6.2
47 + 6.4
52 + •00
49 + 6.7
48 + 6.1
47 + 7.0
44 + 00 • o
TABLE 3
-7 -3Analysis of the Leucotactic Potential of Cyclic GMP (10 M - 5 x 10 M) using 
a) The Method of Boyden and b) The Method of Zigmond end Hirsch
Concentration of 
Cyclic GMP
Boyden System. Cells/HPF/3 hrs. 
Mean and Standard Deviation
Intra-filter penetration jum/40 minutes 
Mean and Standard Deviation
0 21 + 3.8 42 + 7.3
1 X i o “ 7m 21 + 3.1 42 + 6.7
1 X i o ~ 6m 21 + 3.1 43 + 7.9
1 X i o - 5 m 22 + 5.5 42 + 9.4
1 X -410 M 23 + 6.8 42 + 1 0 . 3
1 X M o
1 u> £ * 23 + 6.0 44 + 9.0
2.5 X 1 0 - 3 M 23 + 6.1 44 + 7.2
5 X 10 "3m 15 4 3.1 38 4- 9.8
CO
TABLE 4
- 1 - 3Effects of Cyclic AMP(10 M - 5 x 10 M) on PMN Chemotaxis and Random Migration as measured in 
the Boyden System and Chemotaxis and Chemokinesis as measured by the Technique of Zigmond and Hirsch
DRUG
CONCENTRATION
(Molar)
BOYDEN SYSTEM. CELLS HPF/3 HOURS 
Mean and Standard Deviation
CHEMOTAXIS
INTRA-FILTER PENETRATION yM/40 MIN. 
Mean and Standard Deviation
CHEMOTAXIS CHEMOKINESIS
RANDOM
3% EAS above 
and
6% EAS below
3% EAS above 
and
12% EAS below
3% EAS above 
and
Casein EAS MIGRATION filter fliter below filter
0 144 + 22 216 + 28 25 + 5 75 + 6 81 + 5 64 + 6
1 X io-7m 150 + 20 224 + 28 . 24 + 4 76 + 5 81 + 6 65 + 6
1 X io-6m 151 + 17 217 + 40 25 4- 4 76 + 5 82 + 5 67 + 7
1 X io-5m 147 + 22 226 + 36 26 + 6 74 + 5 81 + 6 66 + 6
1 X -410 M 154 + 24 220 + 18 23 + 4 73 4- 6 81 + 5 63 + 5
1 X i g _ 3 m 139 + 14 196 + 30 30 + 4 75 + 3 82 + 5 64 + 5
1 X i o _ 3 m 145 + 14 222 + 44 26 + 3 75 + 4 80 + 6 65 + 5
1 X i o “ 3m 135 + 22 192 + 23 24 T 5 70 + 5 78 + 5 66 + 5 •^jK.Q
TABLE 5
-7 -3Effects of Cyclic GMP (10 m - 5 x 10 M) on PMN Chemotaxis and Random Migration as measured in 
the Boyden System and Chemotaxis and Chemokinesis as measured by the Technique of Zigmond and Hirsch
DRUG
CONCENTRATION
(Molar)
BOYDEN SYSTEM. CELLS HPF/3 HOURS 
Mean and Standard Deviation
INTRA-FILTER PENETRATION pM/40 MIN. 
Mean and Standard Deviation
CHEMOTAXIS CHEMOTAXIS CHEMOKINESIS
Casein EAS
RANDOM
MIGRATION
3% EAS above 
and
6% EAS below 
filter
3%
12%
EAS above 
and
EAS below 
filter
3% EAS above 
and
below filter
0 149 + 25 233 + 28 25 + 3 71 + 5 78 + 5 63 -f 6
1 X 10-7 144 + 26 ' 240 + 34 27 + 4 72 + 4 79 + 5 64 + 4
1 X io"6 145 + 12 230 + 30 29 + 5 7.1 + 5 78 + 5 64 + 4
1 X 10-5 148J + 23 235 + 31 26 + 6 71 + 6 79 + 6 65 + 5
1 X : o-4 160 + 34 230 + 31 30 + 5 72 ± 6 80 + 5 66 4* 5
1 X 10 “ 157 + 20 230 + 27 27 + 4 74 + 5 82 + 5 66 + 8
2.5 X 10-3 146 + 15 234 + 28 24 + 3 74 + 5 82 + 5 64 + 7
5 X io"3 143 + 24 237 26 23 + 4 73 + 7 80 + 7 63 + 4
c:c
TABLE 6
Effects of Dibutyryl cyclic AMP (10 ^M- 5 x 1 0  3M) on PMN Chemotaxis and Random Migration as
measured in the Boyden System and Chemotaxis and Chemokinesis as measured
by the Technique of Zigmond and Hirsch
DRUG
CONCENTRATION
(Molar)
BOYDEN SYSTEM. CELLS HPF/3 HOURS 
Mean and Standard Deviation
CHEMOTAXIS
INTRA-FILTER PENETRATION yM/4 0 MIN. 
Mean and Standard Deviation
CHEMOTAXIS CHEMOKINESIS
RANDOM
3% EAS above 
and
6% EAS below
3% EAS above 
and
12% EAS below
3% EAS above 
and
Casein EAS MIGRATION filter filter below fi
0 151 -f 22 230 + 29 24 + 5 71 + 7 82 + 6 63 + 5
1 X io”7 143 + 24 234 + 38 25 J. 4 70 •- 4 81 + r 65 + 5
1 X
V0oH 151 + 23 244 + 21 25 + 6 71 + 7 82 + 6 65 + 6
1 X xo-5 1699+ 31 242 + 33 28 + 6 72 .L 4 85 + 8 68 + 4
1 X 10~4 146 + 31 221 + 42 31 + 5 75 + 5 86 + 9 75 + 7
1 X 10-3 163 + 27 212 + 33 37 + 5 74 + 4 85 J. 5 80 + 5
2.5 X io-3 138 + 20 228 + 21 39 + r*J 70 + 7 84 + 7 78 + 4
5 X 10~3 136 + 18 213 + 30 31 + 4 70 + 5 79 6 72 + 6 o:
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TABLE 7
The Effects of Dibutyryl cAMP on PMN Chemokinesis and True Chemotaxis using EAS
as Leucoattractant
a) Without Dibutyryl cAMP
% EAS below filter
- 3b) 10 M dibutyryl cAMP above and below
the filter
1 EAS below filter
1.5 12
The effect of varying concentration gradients and absolute concentration of EAS on the motility 
of human neutrophils in the presence and absence of 10~3m d'cAMP. Figures along the diagonal 
from upper left to lower right show the distance migrated (pm) in increasing concentrations of 
the leucoattractant in the absence of a concentration gradient. Above the diagonal, cells are 
moving in a positive gradient, and below the diagonal in a negative gradient. The figures in 
brackets are estimates of what migration would have been in each of the tests, assuming that 
the cells detected the absolute concentration Oi. the chemoattractant but not the gradient.
xNJ
TABLE 8
Analysis of the Effects of Dibutyryl cAMP on True Chemotaxis.
Data recorded in Table 7
Positive Gradients TRUE CHEMOTACTIC INCREMENTS Inhibition 
of True Chemo­
taxis %% EAS above filter
% EAS below 
filter Control 10 Dibutyryl cAMP
1.5 3 4 0 200
1.5 6 9 -2 100
1.5 12 10 -2 100
3 . 6 10 7 30
3 12 12 2 83
6 12 6 -1 100
coCO
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Table 8 (page 83). Dibutyryl cAMP causes a marked 
reduction of directed motility. These results are 
highly statistically significant (p ~ <^0.001 comparing 
all chemotactic increments for the control group with 
those of the d 'cAMP treated group).
DISCUSSION
A number of authors have reported neutrophil chemo- 
tactic activity for cAMP (Leahy et al, 1970; Gammow 
et al, 1971; and Rivkin and Becker, 1976); these findings 
have been disputed by others. In the present study no 
leucotactic activity could be demonstrated for cAMP or 
cGMP at fairly wide concentration ranges, encompassing 
cAMP concentrations which ha,Te previously been reported 
to be chemotactic. As well as the Boyden system the method 
of Zigmond and Hirsch was also employed to assess leuco­
tactic activity at a shortened time interval. The results 
of both techniques were confirmatory. The difference in 
results between this study and Lhose in which cAMP has 
been reported as being chemotactic are hard to explain. 
Identical filter assay systems and indicator cell types 
have been used by groups who have reported opposite findings,
Similarly no effects on neutrophil random migration or 
chemotaxis to casein and EAS could be detected by treatment 
of neutrophils with cAMP or .cGMP, The concentration 
ranges employed for both cyclic nucleotides included those 
which have been previously reported to exert effects on 
neutrophil motility. Inhibition of neutrophil chemotaxis 
by cAMP has been reported by Rivkin and Becker (1976) and 
Hill et al3 (1975). (Inhibition reported by Rivkin and
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Becker was variable and only evident at high concentra­
tions; Hill et al, reported striking inhibition at low 
concentrations) . Tse et at, (.1972) have reported that 
c.AMP mediates inhibition of random motility (d'cAMP 
is without effect) whereas Rivkin and Becker (1976) 
have reported stimulation of neutrophil random motility 
by both cAMP and d'cAMP. Although cAMP and cGMP were 
without effect in this study, d'cAMP on the other hand 
exerted a two-fold effect on cell motility, as indicated 
by checkerboard results. A marked inhibition of true 
chemotaxis 'was evident with a concomitant st-mulation of 
random motility and chemokinesis. These results are in 
agreement with those of Rivkin and Becker (1976) who 
reported essentially similar findings for d'cAMP over an 
identical concentration range.
The cGMP results are at variance with those of 
Estensen et at, (1973) and Hill et at, (1975) who reported
stimulation of neutrophil chemotaxis by cGMP.
In conclusion this study has indicated that the 
cyclic nucleotides cAMP and cGMP are not chemotactic, 
neither do they affect neutrophil random migration and 
chemotaxis. This may reflect absence of intracellular 
penetration (at least of cAMP) due to poor interaction 
of charged cyclic nucleotide with the hydrophobic cell 
membrane (henion et al, 1967). Dibutyryl cAMP is a 
more lipid soluble congener of cAMP, and the effects of 
this agent may reflect a differential permeability. The 
effects of cAMP elevating agents on neutrophil motility
8 6 .
are discussed at greater length in Chapter VII and 
those of cGMP in Chapter VI.
Finally, the results of this sfudy indicate the 
necessity of using the method of Zigmond and Hirsch 
to enable correct interpretation of experimental data. 
This is evident for d'cAMP in the Boyden system where 
inhibition of chemotaxis was masked by a stimulation of 
random migration. However, data obtained from the 
checkerboard experiment revealed the true situation.
C H A P T E R  VI
Effects of Levamisole, Acetyl Choline and 
Carbamyl Choline on Neutrophil Motility
in vitro
8 7.
INTRODUCTION
Levamiscle (LMS) a potent anti-helminthic agent, 
has been reported to possess' immunostimulatory 
properties with regard to cell mediated immunity 
(Renoux and Renoux, 1972; Tripodi et at, 197?; and 
Hirshaut et at, 1973) . In addition, stimulation of 
phagocytic activity of neutrophils (De Cree et at,
1974) and macrophages (Hoebeke and Franchi, 1973) 
has been reported. Preliminary data reported by 
Hill and Quie (1975) indicate that levamisole con­
sistently increased the chemotactic responsiveness 
of neutrophils from patients with defective leucocyte 
motility. The same group (Estensen et at, 1973 
and Hill et at, 1975) has reported that agents which 
promote elevation of intracellular cGMP levels, such 
as acetyl choline and carbamyl choline, promote 
increased neutrophil chemotaxis. This study examines 
the effect of levamisole, acetyl choline and carbamyl 
choline on neutrophil random migration and chemotaxis. 
Checkerboards, where justified, were performed to assess 
types of motility affected.
It has previously been reported that LMS increases 
intracellular levels of cGMP in murine lymphocytes and 
it was of interest to determine if the.drug was 
acting in a similar way on human PMN. For this reason, 
intracellular cyclic nucleotide estimations have been
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performed on chemotactically stimulated cjlls in 
the presence and absence of I,MS.
MATERIALS AND METHODS
Levamisole (L-2,3,5,6-tetra~hydro-6~ phenylimidazo 
(2,1-b)thiazole)was supplied by Ethnor Laboratories, 
Johannesburg, South Africa. Acetyl choline (99% 
purity) and carbamyl choline (99% purity) were 
obtained from the Sigma Chemical Company (St. Louis, 
Missouri).
Leucoattractants
Two chemotactic agents were used in this study.
a) EAS
b) Alkali hydrolysed casein (600 yg/ir .)
The preparation of both leucoattractants has 
been described in Chapter IV (Page 49).
Cell motility studies
The experimental design was identical to that in 
Chapter V for both acetyl choline and carbamyl choline. 
Random migration and chemotaxis to EAS and casein was 
assessed using the method of Boyden, Chemotaxis (using 
two fixed positive gradients of EAS) and chemokinesis 
(using 1 fixed equal concentration of EAS above and 
below the filter) were also investigated, using the 
method of Zigmond and Hirsch. Preliminary levamisole
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effects were explored using only the Ljyden system.
For levamisole studies the cell concentration used 
for random migration and chemotaxis to casein was 
adjusted to 3 x 10u PMN/'ml. to permit comparison 
between the three experimental groups (random migra­
tion, chemotaxis to EAS and casein). The effects 
of levamisole on the kinetics of neutrophil chemo- 
tactic responsiveness to EAS were also performed at 
1, 2, 3, 4 and 5 hours.
Three checkerboards, employing varying concentra­
tions in all possible combinations of EAS (1.5%, 3%,
6% and 12%) above and below the filter were also per­
formed to assess the exact effects cf levamisole
-3(10 M) on neutrophil motility.
The concentration ranges investigated were 
- 7  - 31 x 1 0  M - 5 x 10 M for acetyl choline and carbamyl
-9 -2choline, and l x  10 M - l x l O  M for levamisole.
The drugs were preincubated with neutrophils for 
20 minutes prior to addition to chambers and remained 
in contact throughout. For checkerboard studies 
EAS was added to the cells prior to addition to the 
chambers.
Using these techniques, the normal range for 
chemotaxis using EAS as leucoattractant was 180 - 240 cells/ 
HPF, using casein 6C - 100 cells/HPF and in random migra­
tion systems, 15 - 30 cells/HPF.
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Pulsing experiments
A number of pulsing experiments were performed
in which PMN prior to chemotactic testing, were
- 3treated with 10 M LMS for 60 minutes after which 
time they were washed twice, resuspended to a con-
gcentration of 3 x 10 /ml and placed in the upper
compartment of the chemotaxis chamber. Positive
and negative controls consisted of PMN which were
identically processed, Negative controls underwent
-3no exposure to LMS whereas 10 M LMS was added to 
positive controls prior to chemotactic stimulation 
and was present throughout the incubation period.
In addition, in another series of experiments 
PMN were treated with levamisole -t EAS (25%) or with 
EAS alone. After 60 minutes these cells were washed 
twice and tested for chemotactic responsiveness to 
EAS. PMN were also pulsed for 60 minutes with 
levamisole + 25% fresh autologous serum or with serum 
alone, and after washing twice were tested for 
chemotactic ability to EAS.
Effect of chemotactic factor with or without LMS on 
neutrophil intracellular cyclic nucleotide levels
To exclude the effects of endotoxin on intracel­
lular cyclic nucleotide levels, EAS was centrifuged in 
an Amicon Centriflo membrane (Amtcon Corporation, 
Lexington, Massachusetts) which retains molecules
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above 50,000 molecular weight. The resultant 
filtrate possessed high chemotactic activity 
and suitable dilutions were used in subsequent 
experiments. Casein was not fractionated.
Peripheral blood was collected as previously 
described and separated in a Ficoll-Hypaque 
gradient. Mononuclear cells were discarded and 
the resultant pellet was resuspended in physiological 
saline and sedimented with a 25% volume of 3% 
gelatin (Difco Detroit, Michigan) for 45 minutes.
The neutrophil-rich layer was collected, centrifuged 
at 250 g for 10 minutes and the resultant cell pellet 
treated with 0.83% ammonium chloride at 4°C for 10 
minutes to lyse residual erythrocytes. The remaining 
cells which consistently contained greater than 90% 
viable PMN were washed in medium 199 and resuspended
7to a final volume of 2 x 10 PMN/ml. Cell suspensions 
(0.5 ml.) were treated with 0.5 'ml. of medium 199 
containing ("C5a" or casein) and were incubated in a
Qshaking water bath at 37 C. After varying incubation 
times (0, 1, 3, 5, 10, 20, 30, 45 and 60 minutes) the 
reaction was terminated by the addition of an equal 
volume of cold 2% perchloric acid. PMN in each tube 
were were disrupted in an MSE ultrasonic disintegrator 
for 2\ minutes at an amplitude of 30 y peak to peak. 
The specimens were then centrifuged at 5 .,000 g for 
10 minutes, the pellet discarded and the supernatant 
restored to pH 7.0 by the addition of 0.3N KOH.
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Specimens were dried on a Vertis lyophyliser. 
Specimens were reconstituted in 0.05M sodium acetate 
buffer, pH 6.2 and aliquots .of 0.2 ml. were used for 
cyclic GMP and 0.1 for cyclic AMP estimations. The 
Schwarz/Mann cyclic AMP and GMP radioimmunoassay 
kits and the procedures supplied with each kit were 
used. Standard curves were run with each assay and 
were found to be consistently linear. Duplicate 
samples were assayed and the final results expressed
7as p moles/10 PMN.
RESULTS
As can be seen in Tables 9 and 10 (pages 97 and 
98 ) acetyl choline arid carbamyl choline at all concen­
trations tested in both assay systems exerted no 
detectable effects on neutrophil motility.
However, as can be seen in Fig.II (Page 99)parallel
assessment of the effect of different concentrations of
LMS on both chemotaxis and random migration indicates
-3 -4that the drug at concentrations of 10 M and 10 M when 
added to PMN in the upper compartment of the chamber 
consistently induced increased chemotaxis to both EAS 
and casein. Random migration was also increased at 
these concentrations. The extent of stimulation for all 
three groups at both LMS concentrations is statistically 
significant (p = <0.001). The mean stimulation values 
(%) with ranges are shown in Table II. (See page 93)
TABLE II
Mean Values and Ranges (%) of Levamisole Stimulation 
of Random Migration and Chemotaxis to EAS and Casein
Levamisole
Concentration
% Stimulation of Chemotaxis EAS Casein
% Stimulation of 
Random Migration
io“3m 72(50-120) 70(41-108) 120(60-153)
-410 M 37(30-65) 40(28-59) 72(46-102)
The effect, of levamisole on neutrophil chemotaxis
- 5to EAS over a closer concentration range (10 M -
10 M^) is shown in Figure ill (page 100) . As can be
seen stimulation of chemotaxis is linear from 
-5 -310 M - 2,5 x 10 M. As was previously observed, 
inhibition of motility was evident at 10 M^.
The results of kinetic experiments using a fixed
-3levamisole concentration (10 M) are shown in Figure 
IV (page 101). Results are expressed as mean values 
of triplicate filters of one experiment only. The 
stimulation produced by levamisole was noticeable 
after 1 - 2  hours and reached its maximum at 3 hours.
The results of the experiments utilising different
combinations of EAS above and below the filter in the
— 3presence and absence of 10 "M levamisole are shown in 
Tables 12a, 12b and 12c (pages 102, 103 and 104 
respectively). From these results it is evident that
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stimulation of cell movement in the presence of
LMS occurs in both positive (above the diagonals)
and negative (below the diagonals), and in the
absence of a gradient (within the diagonals).
The data recorded in these tables on the affects of 
- 310 M levamisole on chemokinesis and true chemotaxis 
are analysed and summarized in Table 13 (Page 105). 
Statistical analysis of the combined increments of 
chemokinesis for all chemokinesis systems, and 
true chemotactic increments for all positive 
gradients indicate that the differences are highly 
significant (p = <0.001 for both groups), The 
method of calculation of true chemotactic increments 
is shown in Chapter IV (Page 59).
Pulsing experiments
To further understand the nature of the LMS 
cell interaction, pulsing experiments were performed. 
As can be seen in Table 14 enhancement of chemotaxis 
was dependent upon the presence of LMS in the system 
containing the PMN cells during chemotactic stimula­
tion, Preincubation of cells with LMS followed by 
washing after 60 minutes resulted in no subsequent 
stimulation. However, when the cells were pulsed 
(60 minutes) with LMS in the presence of a small 
concentration of PAS o1- fresh serum, subsequent 
chemotactic enhancement was observed. This treatment
with LMS abolished the inhibition due to "deactiva­
tion" which was noted when the cells were pulsed 
with EAS alone. The level of stimulation produced 
by pulsing PMN with LMS and EAS was not, however, 
as great as that which was observed when LMS alone 
was present throughout the incubation period
(p <0.001).
Effect of LMS and partially purified serum derived 
chemotactic factor and casein on cyclic nucleotide
levels
As can be seen in Fig. V which is a mean of six 
similar experiments (with standard error of the mean) 
when purified PMN were treated with serum derived 
chemotactic factor an initial elevation of intracellular 
cAMP occurs after 1 - 3  minutes with subsequent restora­
tion to basal levels. The regression coefficients with 
standard deviations in the presence and absence of LMS 
v:ere - 0.033 + 0.017 and - 0.035 + C.021 respectively, 
(regression analysis). These were not significantly 
different from each other nor were they different from 
zero.
Intracellular cGMP levels (Fig. V) after an 
initial slight depression which corresponded to the 
cAMP rise showed a peak of synthesis at 3 - 5 minuces 
and gradually diminished over 60 minutes.
Regression analysis of cGMP levels in the presence 
and absence of LMS yielded regression coefficients 
of -0.0075 + 0.0033 and -0.0139 + 0.0037 respectively, 
indicating similar rates of depletion. These values 
were not significantly different from each other but 
were significantly different from ze^o with p values 
of <0.03 for LMS and <0.001 in the absence of LMS.
However the cGMP values and 5, 10, 20, 40 and 60 
minutes were significantly different in the presence 
and absence of LMS (p <0.001) .
Casein, on the other hand, mediated no significant 
elevation of CAMP at any time interval tested (results 
shown in Figure VI page 108). The regression coefficients 
with standard deviations in the presence of levamisole 
were -0.0223 + 0.014 and 0.0165 + 0.0156 respectively. 
These were not significantly different from each other 
nor were they different from zero. Intracellular cGMP 
profiles resembled those of fractionated EAS, although 
no peak of synthesis was evident. Regression analysis 
of cGMP levels in the presence and absence of LMS gave 
regression coefficients of -0.011 + 0.004 and -0.008 +
0.0038 respectively, indicating similar rates of 
depletion. However, the cGMP values at 5, 10, 20, 40 
•and 60 minutes were significantly different in the 
presence and absence of LMS (p <0.001).
TABLE 9
The Effects of Acetyl Choline on PMN Random Migration and Chemotaxis to Casein and EAS as
.Evaluated by the Boyden Technique and Chemotaxis and Chemokinesis as measured by
the Method of Zigraond and Hirsch
BOYDEN SYSTEM, CELLS/HPF/3 HOURS 
MEAN AND STANDARD DEVIATION
CHEMOTAXIS
INTRA-FILTER PENETRATION pM/40 MIN. 
MEAN AND STANDARD DEVIATION
CHEMOTAXIS CHEMOKINESIS
Drug
Concentration
(Molar) Casein EAS
Random
Migration
3% EAS above 
and 6% EAS 
below filter
3% EAS 
and 12 
below
■ above 
:% EAS 
filter
3% EAS abov3 
and
below filter
0 135 + 21 212 + 31 28 + 6 69 + 8 31 i* 9 61 + 6
1 X i W 7 142 + 26 206 + 32 22 + 7 70 + 7 79 + 9 61 + 5
.1 X 10-6 129 + 30 198 + 27 2-3 + 6 71 4* 8 78 9 60 + 7
1 X 10-5 136 + 21 203 •f 26 20 + 8 72 + 6 78 4* 8 58 + 6
1 X
VF1O ■—1 138 + 17 221 + 22 25 + 9 73 + 8 76 + 6 62 + 4
1 X 10-3 141 + 19 219 + 31 26 + 5 72 + 9 77 + 9 63 7
5 x 10" 3 129 + 25 232 + 29 22 + 4 70 + 5 79 + 7 62 + 6
5 x 10-3 135 + 32 221 + 19 25 + 8 70 + 8 80 + 9 60 4- 5
TABLE IQ
The Effects of Carbamyl Choline on PMN Random Migration and Chemotaxis to Casein and EAS as
Evaluated by the Boyden Technique and Chemotaxis and Chemokinesis as measured by the
Method of Zigmond and Hirsch
BOYDEN SYSTEM, CELLS/HPF/3 HOURS 
MEAN AND STANDARD DEVIATION
INTRA-FILTER PENETRATION yM/40 MIN, 
MEAN AND STANDARD DEVIATION
Drug
Concentration
(Molar)
CHEMOTAXIS 
Casein EAS
Random
Migration
CHEMOTAXIS
3% EAS above 3% EAS above 
and 6% EAS and 12% EAS 
below filter below filter
CHEMOKINESIS
3% EAS above 
and
below filter
0 161 + 31 243 4* 31 26 + 6 64 + 6 70 + 8 55 + 7
1 X 10'-7m 150 + 27 248 + 36 25 + 8 66 + 8 71 + a 54 + 5
7JL X 10"-6m 163 + 30 232 + 28 24- + 6 65 + 7 69 + 8 53 + 4
1 X 10''5m 162 + 25 226 + 24 19 + 5 63 + 6 62 + 6 55 + 6
1 X 10''4m 148 _L 19 261 + 25 26 + 4 62 •4- 5 68 + 9 56 _i_ 7
1 X 10''3m 156 + 28 240 + 26 27 + 4 61 + 6 69 + 8 6 5 JL. 5
2.5 X 10"'3m 142 + 27 231 + 27 28 + 6 62 + 6 6 6 + 7 54 + 5
5 X 10''3m 155 + 25 239 + 28 25 + 6 63 + 6 ' 68 + 8 57 + 6
VOOD
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f ~9 —2Figure _5L Effect of levamisole^lO M - 10 M) on
neutrophil random motility (o) and chemo- 
taxis to casein (©) and EAS (ra). Fesults 
are expressed as mean and standard deviation.
1 0 0  .
Figure JU Effect of levamisole (10~5M - 10 2M)
on neutrophil chemotaxis to EAS. Results
are expressed as mean and standard error.
Figure IV
101 .
Kinetics cf neutrophil chemotaxis to
a) EAS, b) casein and c) random
-3migration, in the presence of 10 M
ievamisole.
EAS as Chemoattractant 
Experiment 1
TABLE 12a
The Effects of Levamisole on PMN Random Migration, Chemokinesis and True Chemotaxis using
a) Control b) levamisole on both 
of the filter
sides
% EAS below filter £ EAS below filter 
0 1.5 3 6 12
0 > 54^v.
1.5 86 (80) 96(80) 108(8:
3 71 (80>\ 8 0 \ ^ 105(80) 112(8 C
6 75(80) 75 (80^^ 8 0 ^ . 111(80
12 66(80) 66 (80) 84 (80)^\  80"\
The effect of varying concentration gradients and absolute concentration of EAS on the motility 
of human neutrophils in the presence and absence of 10“^M levamisole. Figures along the diagonal 
from upper left to lower right show the distance migrated (ym) in increasing concentrations of 
the leucoattractant in the absence of a concentration gradient. Above the diagonal, cells are 
moving in a positive gradient, and below the diagonal in a negative gradient. The figures in 
brackets are estimates of what migration would have been in each of the tests, assuming that 
the cells detected the absolute concentration of the chemoattractant but not the gradient.The same applies for the following two checkerboards.
i 0 2
The Effects of Levamioole on PMN Random Migration, Chemokinesio and True Chemotaxis using
EAS as Chemoattractant 
Experiment 2
TABLE 12b
a) Control
% EAS below filter
0 1,5 3 6 12
-3b) 10 M levamisole on both sides 
of the filter
% EAS below filter
0 1.5 3 6 12
O
The Effects of Levamisole on PMN Random Migration, Chemokinesis and True Chemotaxis using
EAS as Chemoattractant 
Experiment 3
TABLE 12c
a) Control b) M levamisole on both sides 
cf the filter
% EAS below filter
0 1 . 5  3 6 12
% EAS below filter
0 1 . 5  3 6 12
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TABLE 13
A n a l y s i s  o f t h e  E f f e c t s  o f  10 M L e v a m i s o l e  on  PMN Random M i g r a t i o n ,  C n e m o k i n e s i s  and T r u e
C h e m o t a x i s f r o m  D a t a  r e c o r d e d  i n T a b l e s  1 2 a ,  1 2 b a n d 1 2 c .
Random M o t i l i t y  a n d  C h e m o k i n e s i s % S t i m u l a t i o n  o f  C o n t r o l
(No g r a d i e n t  o f  EAS p r e s e n t ) Random M o t i l i t y / C h e m o k i n e s i s
T y p e  o f % EAS a b o v e % EAS b e l o w R e p l i c a t e  E x p e r i m e n t s Mean S t i m u l a t i o n
M o t i l i  t y f i l t e r f i l t e r 1 2 3 %
a) Random
0 0 3 5 24 40 33M i g r a t i o n
b) C h e m o k i n e s i s 1 . 5 1 . 5 43 21 31 32
3 3 33 25 22 27
6 6 13 36 23 24
12 12 11 30 18 20
C h e m o t a x i s % S t i m u l a t i o n  o f  C o n t r o l
( P o s i t i v e  EAS g r a d i e n t s  p r e s e n t ) T r u e  C h e m o t a x i s '
% EAS a b o v e % EAS b e l o w % R e p l i c a t e  E x p e r i m e n t Mean S t i m u l a t i o n
f i l t e r f i l t e r 1 2 3 %
b)  T r u e 1 . 5 3 'TOO 0 230 no
C h e m o t a x i s
1 . 5 6 77 33 38 49
1 . 5 12 55 33 59 , 49
3 6 317 0 45 121
3 12 83 0 62 48
6 12 520 150 100 257
10 5.
TABLE 1 4
Results of a Series of 6 Experiments showing the Effect on PMN Chemotactic Responsiveness
_ 3to EAS after pre-treating cells with LMS (10 M) and/or EAS or Serum
Upper Chamber Mean Range p value
Cell.3 per HPF
PMN + M 199 131 104-153
PMN + LMS 251 204-260 <0.001
PMN pulsed with LMS (60 min.) 130 96-158 NS
PMN pulsed with EAS (60 min.) 62 33-74 <0.001
PMN pulsed with EAS + LMS (60 min. 193 164-277 <0.001
PMN pulsed with serum (60 min.) 131 80-210 NS
PMN pulsed with serum + LMS
(60 min.) 139 95-219 <0.001
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Figure V Effects of serum derived chemotactic factor 
(EAS) in the presence (-- ) and absence
/- 3(---) of 10 M levamisole on neutrophil
cAMP and cGMP levels. Results are expressed 
as mean and standard error.
1 0 8  .
Figure VI Effect of casein in the presence (-- )
-3and absence (- - ) of 10 M levamisole on
neutrophil cAMP and cGMP levels. Results
are expressed as mean and standard error.
DISCUSSION
Contrary to the reports of Estensen et at,
(1973) and Hill et al> (1975) acecyl choline and 
carbamyl choline had no detectable stimulatory 
effects on any form of neutrophil motility. The 
reasons for these differences are unclear since 
similar cell types and filter assays have been used 
in both studies.
Although the exact mechanism of action of LMS
is unknown,, it affects a number of cell functions
involved in the immune and inflammatory response.
The data reported here indicate that in a defined
range of concentrations it consistently increases both
directed and random movement of normal PMN cells in
Boyden chambers. The increased chemotaxis produced by
LMS was observed when either EAS‘or casein was used as
chemoattractant. Further experiments indicated that
-5 -3stimulation is evident from 10 M to 7.5 x 10 M being
-5 -3linear in the range 10 M t o 2 . 5 x l 0  M. At a concen- 
-2tration of 10 M inhibition of chemotaxis occurs.
When the kinetics of the stimulatory response were 
studied, it was observed that enhanced chemotaxis was 
present at all time intervals tested but was maximal 
at 3 - 4 hours. Similarly in random migration studies 
LMS at concentrations of 10 M - 10 M significantly 
increased non-directional movement, this effect again
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being maximal at 3 hours.
Using a system which varies the concentration 
of leucoattractant above and below the filter 
(Zigmond and I-Iirsch, 1373) and which ascertains the 
influence of LMS on rate and direction of neutrophil 
locomotion it is evident that not only are chemo- 
taxis and random migration Increased by LMS treatment, 
but also stimulated random migration (chemokinesis). 
Stimulation of chemokinesis is greatest when lower 
concentrations of chemoattractant are present on 
either side of the filter, and presumably higher 
doses of EAS mediate greater "deactivation" which 
may counteract the LMS effect. It was unclear 
whether the effect on chemotaxis was any different 
from the effect on random migration, however usin^ 
the "leading front" technique the results indicate 
that the stimulation of chemotaxis is not due solely 
to increased random migration and chemokinesis, but 
is due also to a true increase of directional move­
ment. The finding that LMS stimulates all three 
types of neutrophil motility suggests that a common 
pathway may be influenced. The results may be of 
potential therapeutic value in the treatment of 
inherited or acquired conditions associated with 
defective PMN chemotaxis. In neonatal rats infected 
with Staphylococcus aureus far greater numbers of PMN 
were observed at the sites of bacterial infection 
in LMS-treated animals than in untreated ones, and 
this was associated with a markedly increased 
survival rate (Fisher et al, 1974), It is
unlikely, however, that the drug concentrations 
at which an effect on motility is seen in vitro, 
are attainable in vivo. To further understand 
the nature of the LMS-PMN interaction, pulsing 
experiments were performed using various combina­
tions of LMS, autologous serum or EAS. These 
results showed that in the absence of serum tne 
LMS effect was not evident. When PMN were pulsed 
with LMS in the presence of either EAS or fresh 
serum -f levamisole how^ever, a chemotactio stimula­
tion was observed suggesting that serum factors 
contribute to the mechanism of LMS action. Pulsing 
with EAS alone induced an inhibition of chemotaxis.
It appears therefore that LMS can eliminate the 
deactivation of chemotactic responsiveness observed 
when PMN are preincubated with chemotactic factors. 
The serum dependence for LMS stimulation was not 
apparent in serum-free random migration systems and 
presumably adherence of the cedis to the filter may 
be sufficient to activate the cells and allow an 
LMS stimulatory effect.
It has previoulsy been reported by Eivkin et a'i,
(1975) that cAMP levels of rabbit peritoneal neutro­
phils are unaltered by interaction with C5a and a 
bacterial chemotactic factor. No studies were 
performed on peripheral neutrophils. Likewise, 
no kinetic studies were carried out. The results
of the present study indicate a differential effect 
of two chemotactic factors on human neutrophil 
cAMP levels. Casein had 'no significant effect on 
intracellular cAMP whereas a chemotactic factor 
derived from endotoxin activated serum mediated 
a significant early increase ( 1 - 3  minutes) in 
cAMP. Levamisole had no effect on cAMP levels in 
cells treated with both leucoattractants. Further­
more both chemotactic factors mediated a depletion 
of cGMP levels. With casein the depletion was pro­
gressive throughout the incubation period, whereas 
the chemotactic factor derived from EAS caused an 
early decrease in cGMP levels followed by a peak of 
synthesis with subsequent depletion from 5 - 6 0  
minutes. The early depression paralleled the eleva­
tion in cAMP. For both leucoattractants, levamisole 
promoted an early increase in cGMP levels and although 
depletion of cGMP occurred at similar rates in LMS 
treated or untreated PMN, the levels remained 
consistently higher in LMS treated cells.
Hadden et at, (1975) have demonstrated that LMS 
may increase intracellular cGMP levels in murine 
lymphocytes. Lstcnsen et al, (1973) and Hill et at,
(1975) have reported that exogenous cGMP and cholinergic 
agents enhance neutrophil chemotactic responsiveness 
to a bacterial derived chemotactic factor. However, 
these authors did not demonstrate that these agents
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promoted elevation of intracellular jGMP levels 
in neutrophils and their work could not be con­
firmed in this laboratory.. Concentrations of 
acetyl choline and carbamyl choline which they 
found to stimulate chemotaxis do mediate an eleva­
tion of neutrophil intracellular cGMP levels 
(see Addendum, page 114a), but this may not be 
sufficient to promote increased cell motility. 
However, the results of the present study indicate 
that LMS mediates the maintenance of elevated cGMP 
levels and LMS stimulation of motility may indeed 
be related to raised intracellular cGMP levels.
It has been shown that cAMP plays an important 
role in stimulating the calcium pump for rapid 
calcium efflux, (Fuller et at, 197r* and Gallin 
and Rosenthal, 1974) have shown that interaction of 
PMN with chemotactic factors promotes such a 
calcium efflux which occurs within the first minute. 
These findings correlate with the initial rise in 
cAMP levels durxng exposure to chemotactic factor, 
described in this report. It could be hypothesised 
therefore that after cell-chemotactic factor inter­
action cAMP levels rise initially, perhaps due to 
adenyl cyclase activation, causing a calcium efflux 
which promotes optimal microtubular assembly. On
the other hand, the raised cAMP levels might result
+4from the calcium efflux as Ga dons are known to
inactivate adenylate cyclase. It has also been 
shown that intracellular calcium levels regulate cGMP
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accumulation (Goldberg, 1974) and the decline in cGMP 
levels noted in this study could be related to the 
calcium efflux. Oliver et at, (1974) have reported 
an apparent defect in microtubular assembly in Chediak- 
Higashi neutrophils related to inadequate intracellular 
cGMP levels and suggest that this cyclic nucleotide 
may promote microtubular polymerisation. 1't is likely 
therefore that agents such as LMS, by maintaining cGMP 
levels may sustain microtubular assembly thereby 
enhancing cell motility.
Casein on the other hand, had no effects on neutro­
phil intracellular cAMP levels. Other workers in this 
laboratory (Rabson et at, 1976) have suggested that the 
mechanisms of neutrophil chemotaxis to casein and EAS 
are different, due to different inhibition profiles 
obtained with various inhibitors of chemotaxis. Likewise, 
patients with impaired leucotaxis to EAS have often 
manifested a normal response to casein. Such a patient 
has been reported by Gallin (personal communication, 1976) 
Hydrolysed casein is a less potent ieucoattractant than 
EAS for human blood neutrophils (Anderson, 1974) and this 
may reflect a lesser ability to activate neutrophils.
The differences between EAS and casein are discussed at 
greater length in Chapter IX (page 177),
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ADDENDUM
-5The effects of 10 M acetyl choline and carbamyi 
-4choline and 10 M propanolol, on cGMP levels of 
neutrophils stimulated with 10% EAS for 10 minutes 
are shown in Table 14a below. Results are expressed 
as mean values with standard deviations for 3 
experiments.
Table 14a
The Effects of Acetyl Choline, Carbamyi Choline and 
Propanolol on Neutrophil cGMP Levels
Reaction System
7p moles/cGMP/10 PMN 
Mean and standard deviation
EAS alone 1.0 + 0-3
r~
EAS + 10 
acetyl choline 1,5 + 0,5
EAS + 10“5M 
carbamyi choline 1.9 + 0.5
EAS -r 10"4M 
propanolol 3,0 + 0.6
As can be seen, all three drugs mediate an increase 
of cGMP, However, the increases due to acetyl choline 
and carbamyi choline are slight by comparison with 
propanolol. The latter drug has similar effects on 
cell motility as levamisole (Chapter VII). It is 
probable that the increases in cGMP promoted by acetyl 
choline and carbamyi choline are insufficient to 
influence neutrophil locomotion.
The Effects of Histamine and Metiamide and 
other Agents which mediate Elevated 
Intracellular cAMP Levels on 
Neutrophil Motility
C H A P T E R  VII
1 1 5 .
INTRODUCTION
It has previously been shown that a group of
children with cold staphylococcal abscesses associated
with hyper-immunoglobulinemia E and presumably elevated
serum histamine levels, have defective polymorphonuclear
leucocyte (PMN) chemotaxis (Hill and Quie, 1975).
In a series of in vitro experiments it was demonstrated
— 8 — 3that histamine at concentrations of 10 M - 10 M 
exerted a progressive and profound inhibition of PMN 
chemotaxis, an effect which could be eliminated by an 
H-2 receptor antagonist (Hill and Quie, 1975).
This investigation examines in detail, the effect
of histamine and metiamide, an H-2 receptor antagonist,
and other agents reported to increase intracellular
cAMP levels on PMN random motility, stimulated random
motility (chemokinesis) and true directional motility
(chemotaxis). Analysis of these effects has been
made possible by the advent of the technique of Zigmond
and Hirsch (1973) which employs varying concentrations of
chemotactic factor above and below the filter enabling
/dissociation of random from truly directional motility./vjT tEmploying this system, histamine, d 'cAMP, prostaglandin 
E^ (PGE^) and isoproterenol, have been shown to stimulate 
random migration but to inhibit true chenaotaxis, the net 
effect being one of mild stimulation as assessed in a 
classical Boyden system.
Because histamine has been shown to increase intra-
lib.
cellular levels of cAMP in a number of ^ell types 
(Bourne et al, 1973; Zurier et al, 1974; Beaven,
1976) the extent of cyclic nucleotide involvement 
has been assessed.
MATERIALS AND METHODS
Preparation of drugs Histamine (Sigma Chemical
Company, St. Louis, Missouri), Metiamide (kindly
supplied by Smith, Kline and French, Johannesburg)
and diphenylhydramine hydrochloride obtained from
Park-Davis (Johannesburg) were dissolved in medium
199 (Grand Island, New York) at pH 7.2, giving a
6 “3final concentration range of 10 M - 10 M. Adenosine
6 23' : 5' cyclic monophosphoric acid (cAMP), N O
dibutyryl adenosine 3' : 5' - cyclic monophosphoric 
acid sodium salt (d'cAMP) and L-isoproterenol hydro­
chloride were obtained from Sigma Chemical Company 
(St. Louis, Missouri). Prostaglandin E^ (PGE.) was 
kindly supplied by Dr. John Pike (Upjohn Company, 
Kalamazoo, Michigan) levamisole hydrochloride by 
Ethnor Laboratories (Johannesburg)and propanolol by 
I.C.I. (Johannesburg, South Africa). Drugs were 
dissolved in M199 and diluted according to experimental 
requirements.
Cell motility studies
The motility studies were of two types. The direct 
effects of histamine and metiamide on chemotaxis and 
random migration were assessed by the method of Boyden
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whereby PMN which accomplish complete transfilter 
passage are counted microscopically. To ascertain the 
exact type of cell motility influenced by the drugs, 
the leading front method of Zigmond and Hirsch was 
adopted.
Neutrophils were obtained from 50 ml, of heparinized 
whole blood (5 units heparin/ml.) donated by healthy 
male and female laboratory workers. After sedimentation 
at 37°C, the buffy layer was centrifuged at 250 g for 
10 minutes, The resultant cell pellet was washed three 
times with medium 199 and resuspended to a PMN concentra­
tion of 3 x 10^/ml. for EAS and 5 x 10^/ml, for casein.
Leucoat.tr act ants
Two chemoattractants were used in this study.
a) Fresh serum activated by 500 yg/ml, of bacterial 
lipopolysaccharide (E.ooli 0127 : B8 Difco) (EAS).
The mixture was incubated for 30 minutes at 37°C 
followed by a four-fold dilution with medium 199.
b) Denatured casein at a concentration of 600 yg/ml. 
prepared by alkali hydrolysis with subsequent readjust­
ment to pH 7.2. This preparation was stored at -20°C 
and used for all subsequent experiments,
Chemotaxis assay
PMN chemotaxis was measured using the modified 
Boyden Chamber which utilizes 0.2 ml. of drug treated 
or control cell suspensions in the upper chamber,
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separated from 1 ml. of the leucoattractant solution 
by a 5 p pore size membrane filter (Millipore Corp.). 
Chambers were incubated at 37°C for 3 hours after 
which filters were removed, fixed with methanol and 
stained with haematoxylin. The average number of 
neutrophils per high power field reaching the lower 
surface of the filter was determined and expressed as 
an average for triplicate filters.
Random Migration was assessed by measuring the extent 
of cell migration across the 5 p pore size filter in 
the absence of a leucotactic gradient. 3 x 10^ cells 
were suspended in medium 199 containing 0.1% bovine 
serum albumen and a similar medium was placed in the 
bottom compartment, drugs being added in equal concentra­
tion to both top and bottom compartments.
Using these techniques the normal range for chemo- 
taxis using EAS as chemoattractant was 180 - 2^0 cells/HPF., 
using casein 120 - 165 cells/HPF and in random migration 
systems 15 - 30 celis/IIPF.
Simultaneous assessment of drug effects on different 
types of neutrophil motility
To ascertain the effect of histamine or metiamide on 
specific types of neutrophil motility, i ,*e. random 
migration, chemokinesis and true chemotaxis, PMN 
migration was assessed when varying concentrations of EAS 
(1.5%, 3%, 6% and 12%) were placed above and below the 
filter in all possible combinations according to the
11 9 .
method of Zigmond and Hirsch (1973). Sy^cems so 
designed were of 2 types, without drugs and with 
2.5 x 10 histamine or metiamide above and below 
the filter. Chambers were incubated at 37°C for 
40 minutes, filters were fixed, stained, dehydrated 
cleared and mounted with the top side uppermost. 
Neutrophil migration was expressed as the distance 
travelled (pm) as measured with the optical micrometer 
on the fine focus of the microscope. Results are 
expressed in tabular form ("checkerboard") and true 
chemotaxis is taken as the difference between the 
observed values for positive gradients (above the 
diagonal lines) and the estimated values based on 
chemokinesis (in brackets) according to the formula 
of Zigmond and Hirsch. The effects on chemotaxis are 
assessed as previously described by comparing true 
increments for a given gradient i.n the presence or 
absence of the drugs. Percentage stimulation or 
inhibition is calculated according to the formula:
Drug value - Control value 
Control value
Dose Response Experiments
a) Chemotaxis
To assess the effects of varying concentrations of 
histamine and metiamide (10 - 10 M^) on true chemo­
taxis, a fixed positive gradient was selected (3% EAS 
above the filter and 12% EAS below the filter) and the 
true chemotactic values for each drug concentration
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were calculated from the corresponding chemokinesis 
values as described above. Results are expressed as 
a percentage of the true chemotactic values observed 
in control systems without histamine or metiamide,
b) Chemokinesis
Using the same drug concentration range and a 
fixed chemokinesis system (3% EAS above and below the 
filter) the effects of histamine and metiamide on 
chemokinesis were evaluated and results were expressed 
according to the formula:
Experimental value - Control value ,„„ 1________________________________ x 100
Control value
Drug Exclusion Experiments 
a) Histamine/Metiamide
To assess the reversibility of the histamine mediated
effect on true chemotaxis, cells were pre-treated with 
-6 -4 'histamrne (10 M - 10 M) for 20 minutes followed by
_5exposure to metiamide (2.5 x 10 M). The true chemotactic 
increments were calculated using a fixed positive gradient 
(3% EAS top : 12% EAS bottom) with the corresponding chemo­
kinesis systems. The effects of metiamide on the true 
chemotactic response of histamine treated PMN were 
evaluated by comparison of the experimental values with 
the corresponding negative (no histamine or metiamide) and
-6 **4positive (10 M - 10 M histamine only) controls.
In reverse experiments PMN were treated with metiamide 
(10 ^M - 10 M^) followed by exposure to 2.5 x 10 ^M 
histamine (final concentration) and similar calcula­
tions performed.
b) Histamine or Metiamide/Levamisole
Using the same histamine and metiamide concentra­
tion ranges, PMN were treated as above and exposed to 
_ 3levamisole (10 M) after which they were tested for
true chemctactic responsiveness. In the reverse
-5experiments cells incubated with levamisole (10 M -
-3 -510 M) were subsequently treated with 2 x 10 M
histamine or metiamide. Experimental planning was as 
above and results calculated accordingly.
Other Chemotactic Studies
a) Effect of Histamine on PMN motility using casein
as leucoattractant
This was assessed using varying concentrations of 
casein (15, 30, 60 and 120 yg/ml.) above and below the 
filter in the absence and presence of histamine
-5(2.5 x 10 M) on both sides of the filter.
b) Effect of drugs known to alter intracellular
cAMP levels
Using predetermined concentrations based on
pioneer dose response experiments, the effects of d 'cAMP 
-3 -4(10 M) isoproterenol (10 M), PGE^ (10 yg/ml.), and 
-4propanolol (10 M), on chemokinesis and chemotaxis were
] 2 2 .
assessed in "checkerboard" systems using varying 
EAS concentrations (1.5%, 3%, 6% and 12%) above 
and below the filter.
Cyclic nucleotide studies
Peripheral blood was collected as previously 
described and separated on a Ficol1-Hypaque gradient. 
Mononuclear cells were discarded and the resultant 
pellet was resuspended in physiological saline and 
sedimented with a 25% volume of 3% gelatin (Difco, 
Detroit, Michigan) fo** 15 minutes. The neutrophil- 
rich layer was collected, centrifuged at 250 g for 
10 minutes and the resultant cell pellet treated with 
0.83% ammonium chloride at 4°C for 10 minutes to lyse 
residual erythrocytes. The remaining cells which 
consistently contained greater than 9us viable PMN 
were washed in medium 199 containing 5% foetal calf 
serum (Burroughs Wellcome) and resuspended to a final
7volume of 2 x 10 PMN/ml. Cell suspensions (0.05 ml.) 
were treated with 0.5 ml, of medium 199 containing
-55 x 10 M histamine or metiamide and were incubated in 
a shaking water bath at 37°C. After varying incubation 
times (0, 1, 3, 5, 10, 20, 30, 45 and 60 minutes) the 
reaction was terminated by the addition of an equal 
volume of cold 2% perchloric acid. PMN in each tube 
were disrupted in an MSE ultrasonic disintegrator for 
7\ minutes at an amplitude of 30 y peak to peak. The 
specimens were then centrifuged at 5,000 g for 10 
minutes, the pellet discarded and the supernatant
restored to pH 7.0 by the addition of 0.3N KOH. 
Specimens were re-centrifuged for 20 minutes, and 
were then freeze-dried on a Vertis lyophiliscr. 
Specimens were reconstituted in 0.05 M sodium acetate 
buffer, pH 6.2 and aliquots of 0.2 ml, were used for 
cyclic GMP and 0.1 ml. for cyclic AMP estimations.
The Schwarz/Mann cyclic AMP and GMP radioimmuno^assay 
kits and the procedures supplied with each kit were 
used. Standard curves were run with each assay and 
were found to be consistently linear. Duplicate 
samples were assayed and the final results expressed
7as p moles/10 PMN.
RESULTS
Parallel assessment of the effect of different
concentrations of histamine on both chemotaxis and
random migration using the classical Boyden technique
is shown in Fig.Vila (page 128). .At concentrations of 
-5 -5between 1 x 10 M and 5 x 10 M, histamine when added 
to the PMN in the upper compartment of the chamber, 
consistently appeared to cause a moderate increase in 
random migration and in chemotaxis when both EAS and 
alkali hydrolysed casein were used as chemoattractants 
(p <0.05 Wilcoxon test). Likewise metiamide ac 
equivalent concentrations (Fig.Vlb) produced similar 
effects on both chemotaxis and random migration 
(p <0.05).
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The results of the experiments utilizing
different combinations of EAS above and below the
-5filter in the presence and absenct. of 2.5 x 10 M 
histamine or metiamide, these being the concentra­
tions which exerted optimal responses in Fig, Vila 
and Vllb as shown in Tables 15a, 15b, 15c and 
16a, 16b and 16c. It is evident that stimulation 
of cell movement in the presence of histamine occurs 
only in the absence of a gradient (within the diagonal 
lines) and in .the presence of a negative gradient 
(below the diagonal). These results indicate that 
histamine produces stimulation of both random migra­
tion and chemokines.
To assess the effect of both these drugs on 
directional motility, the true increments in chemo- 
taxis between control and drug treated cells were 
compared.
Results of these calculations from the data 
shown in the above Tables and are summarized in 
Tables 17 and 18. It can be seen that histamine 
induced a marked inhibition of true chemotaxis for 
all positive gradients tested (p <0.001) whereas 
metiamide had no effect on the true chemotactic 
increment.
To determine whether the histamine induced
inhibition of true chemotaxis was dose-dependentr
the effects of the drug at a concentration 
— 6 — 3range of 10 M - 10 M were assessed. As can be seen 
in Fig. Vlll page 137) progressive inhibition was observed
In-6 -5from 10 M, and was maximal at 2.5 x 10 M.
further dose response experiments the parallel
effects of histamine and metiamide on chemokinesis
were estimated (Fig. IX) . Stimulation of chemokinesis
at histamine concentrations between 10 -
-410 M was observed, with optimal stimulation at 2.5 x
10 ~*M. faith metiamide a progressive increase from 
-6 -510 M to 5 x 10 M was noted. The respective inhibitory 
and stimulatory effects of histamine on PMN chemotaxis 
and chemokinesis were also evident when hydrolysed casein 
was used in varying concentrations above and below the 
filter (Table 19, Page 139).
To assess whether the inhibition of chemotaxis
induced by histamine treatment was reversible, a series
of experiments were performed in which cells initially
pre-incubated for 20 minutes with histamine at a con-
-6 -4centration range of 10 M - 1 0  M, were then exposed to
— r2.5 x 10 M metiamide. This latter treatment had no
significant effect on the extent of inhibition of true
chemotaxis. (Fig. X ). In the reverse experiment
PMN were initially treated with a corresponding
concentration range of metiamide for 20 minutes and
-5subsequently exposed to 2,5 x 10 M histamine, a 
concentration which produces approximately 100% 
inhibition of true chemotaxis. This effect could be 
completely abolished at metiamide concentrations of 
10 and upwards (Fig. XI). Additive effects of
1 2 6 .
histamine and metiamide on chemokinesxs were
evident only at drug concentrations of less than 
- 510 M and these we^e controlled for experimentally
and corrected for in calculations of true chemo-
tactic increments. In similar experiments cells
-4pre-treated with 2.5 x 10 M diphenylhydramine, a 
concentration which has previously been shown to have 
no effect on neutrophil motility, manifested total
r~
inhibition of true chemotaxis upon exposure to 2.5 x 10 M 
histamine. Similarly this drug had no effect on the 
histamine induced stimulation of chemokinesis.
Results are shown in Tables 20 and 21 (Pages 142 
and 143 respectively).
In a further series of experiments PMN either
prior or subsequent to histamine tree ment were exp' jed
to levamisole, an agent known to increase random
migration, chemokinesis and true chemotaxis. When
cells were initially treated with histamine followed by
exposure to 10 levamisole, a concentration shown to
produce marked stimulation of neutrophil motility,
this stimulation could be abrogated (Fig XII),
-6 -4However, metiamide (10 M - 10 M.) pre-treatment of PMN
had no effect on the levamisole stimulation. (Results 
not shown). Furthermore, the stimulation of chemotaxis 
produced by initial levamisole treatment could not be 
reversed by a subsequent inhibitory concentration of 
histamine. (Fig. XIII).
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To ascertain if the histamine and metiamide 
effects on neutrophil motility could be attributed 
to changes in intracellular cyclic nucleotide levels, 
Doth intracellular cAMP and cGMP were measured 1 - 6 0  
minutes after drug treatment. Results depicted in 
Fig. XIV, which is a mean of 3 experiments all having 
similar profiles, indicates that intracellular levels 
of cAMP are elevated soon after histamine treatment 
reaching maximal levels between 5 and 20 minutes.
'When PMN are treated with metiamide, an initial 
increase of cAMP is noted after 1 minute rapidly drop­
ping to within normal limits for the remainder of the 
experiment. cGMP levels were unaffected by both 
drugs.
To determine whether the histamine stimulation 
of PMN random migration and/or the inhibition of 
chemotaxis was related to the increase in intracellular 
cAMP levels, cell movement v/as assessed after PMN had 
been treated with compounds known to increase intra­
cellular cAMP levels. As is seen in Tables 22 and 23,
-3 -4d 'cAMP (10 M) , isoproterenol (10 M) and PGE^ (10 yg/ 
ml.) all produced significant increases in random migra-
-3tion and inhibited true chemotaxis. cAMP (5 x 10 M) 
was without effect on neutrophil motility. Propanolol, 
a 6-blocker, actually mediated an increase in both 
chemokinesis (43%, 30%, 26%, 24%) and true chemotaxis
(0%, 16%, 41%). (Table 24, Page 149).
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Figure Vll The effects of a) histamine and b) metiamide
on PMN chemotaxis to (A) endotoxin activated
serum, (B) casein and 
migration systems.
(C) in random
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TABLE 15a
Effects of Histamine on PMN Random Migration, Chemokinosis and True Chemotaxis
Experiment 1
a) Control b) 2.5 x 10 M histamine on both sides
of the filter
% EAS below filter % EAS below filter
0 1.5 3 6 12 0 1.5 3 6 12
The effect of varying concentration gradients and absolute concentration of EAS on the motility 
of human neutrophils in the presence and absence of 2.5 x 10“^M histamine. Figures along the 
diagonal from upper left to lower right show the distance migrated (ym) in increasing concentra­
tions of the leucoattractant in the absence of a concentration gradient. Along the diagonal, cells are moving in a positive gradient, and below the diagonal in a negative gradient.The figures in brackets are estimates of what migration would have been in each of the tests,assuming that the cells detected the absolute concentration of the chemoattractant but not the gradient.
The same applies for the following two Tables
TABLE 15b
a) Control -5b) 2.5 x 10 M histamine on both sides
of the filter
Effects of Histamine on PKN Random Migration, Chemokinesis and True Chemotaxis
Experiment 2
EAS below filter % EAS below filter
0 1.5 3 6 12 0 1.5 3 6 12
OC
T
TABLE 15c
Effects of Histamine on PmN Random Migration, Chemokinasis and True Chemotaxis
Experiment 3
a) Control b) 2.5 x 10 ~^M histamine on both sides of
the filter
% EAS below filter % EAS below filter
0 1.5 3 6 12 0 1.5 3 6 12
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TABLE 16a
Control b) 2.5 x 10 metiamide on both sidesof the filter
Effects of Metiamide on PMN Random Migration, Chemokinesis and True Chemotaxis
Experiment 1
% EAS below filter % EAS below filter
0 1.5 3 6 12 0 1.5 3 6 12
diagonal from upper left to lower right show the distance migrated (^ im) in . increasing concentra­
tions of the loucoattractcnt in the absence of a concentracion gradient. Above tne diagonal, the 
cells are moving, in a positive gradient, and below the diagonal in a negative gradient. The 
figures in brackets are estimates of what migration would have been in each of the tests, assuming 
that the cells detected the absolute concentration of the chemoattractant but not the gradient.
The same applies for the following two Tables.
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TABLE 16b
Effects of Metiamide on PMN Random Migration, Chemokinesis and True Chemotaxis
Experiment 2
a) Control
% EAS below filter
0 1.5 3 6 12
-5b) 2.5 x 10 M metiamide on both sides
of the filter
% EAS below filter
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TABLE 16c
Effects of Metiamlde on PMN Random Migration, Chemokinesls and True Chemotaxls
Experiment 3
a) Control
% EAS below filter
0 1.5 3 6 12
-5b) 2.5 x 10 M metiamide on both sides
of the filter
% EAS below filter
0 1.5 3 6 12
1
3
4
TABLE 17
A n a l y s i s  o f  t h e  E f f e c t s  o f  2 . 5  x 10 M H i s t a m i n e  on  PMN Random M i n r a t i o n ,  C h o n o k i n o s i s  a n d
C h  e mo t  ay.  i s  t : r  o  m D a  t  a r o c o r  d  e d  i n  T  a h  1 c  s 1 '5 a , 1 r> b
a n d  15  c
- 5
T y p o  o f  
Mot . i  i i t y
a) Random 
M i g r a t i o n
b) C h o m o t a x i s
Random M o t i l i t y  and  C h e m o k i n e s i s  
(No g r a d i e n t  o f  EAS p r e s e n t )
l EAS a b o v e  % EAS b e l o w  
f i l t e r  f i l t e r
l
1
S t i m u l a t i o n  o f  C o n t r o l  
Random M i g r a t i o n
R e p l i c a t e  E x p e r i m e n t s
2 3
Mean St i m u l a t i o n
0 0 28 33 37 33
1 . 5 1 . 5 27 19 33 26
3 3 31 2 24 1 9
6 6 38 0 18 1 9
12 12 44 15 21 27
C h e m o t a x i s . % I n h i b i t i o n  o f  C o n t r o l
( P o s i t i v e  EAS g r a d i e n t s  p r e s e n t ) T r u e  C h e m o t a x i s
% EAS a b o v e % EAS b e l o w R e p l i c a t e  E x p e r i m e n t s Mean I n h i b i t i o n
f i l t e r i ' l l  t e r 1 2 3 %
c)  T r u e
C h o m o t a x i s 1 .5
3 1.90 100 ) 00
1 . 5 6 100 100 85
1 . 5 12 57 85 78
3 6 100 100 100
3 12 100 7 5 100
6 12 100 100 100
100 
9 5 
73 
100 
92
100
TABLE 10
A n a l y s i s  o f  t h e  E f f e c t s  o f  2 . 5  x 10 ''M M e t i a m l d e  on  PMN Random M i g r a t i o n ,  C h o m o k i n c s i s  and
C h c m otax is from Data r oc onhnl i. n T;i h 1 o_s_ 1 G a , 1 6 b
a n d  1 6 c
No EAS g r a d i e n t s  p r e s e n t  
(Random M o t i l i t y )
l S t i m u l a t i o n  o f  C o n t r o l  
_____ Random M i g r a t i o n _____
R e p l i c a t e  E x p e r i m e n t s
T y p e  of 
M o t i l i t y
% EAS a b o v e  
f i l t e r
% EAS b e l o w  
f  i I t e r 1 2 3
Mean S t i m u l a t i o n
\
a) Random 
M o t i l i t y 0 0 34 17 16 22
b) C h e m o k i n o s i s 1 . 5 1 . 5 22 7 1 5 1 5
3 3 14 9 17 1 3
6 6 13 14 7 11
12 12 23 15 9 1 6
P o s i t i v e  g r a d i e n t s  p r e s e n t  
( C h e m o t a x i s )
% S t i m u l a t i o n  o f  Cor , t  
T r u e  C h e m o t a x i s
r o l
f % EAS a b o v e  
f i l t e r
% EAS b e l c w  
f  i 1 t e r 1
R e p l i c a t e  E x p e r i m e n t s  
2 3
Mean S t i m u l a t i o n
Q.
15
c) T ru e
C h o m o t a x i s i . 5
3 0 0 - i  9 - 5
1 . 5 6 2 2 0 0 7
1 . 5 12 25 0 ' V 1 5
3 6 0 0 -1 - 2
3 1 2 - 8 0 33 8
6 1 2 0 0 25 8
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-  ^--~y t -  v  i l l The inhibitory effeot of increasing concentra- 
tions of histamine on true chemotaxis. To 
calculate these points a fixed positive gradient 
was used throughout (3% EAS top : 12% EAS bottom). 
The true chemotactic values were obtained from 
the difference between the observed chemotactic 
results and the expected values calculated from 
from corresponding chemokinetic results (3 : 3,
6 : 6, 12 : 12 % EAS top and bottom). The 
results depict mean values and the range for
each concentration.
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Fig. IX The stimulatory effect on chemokinesis (3% EAS 
above and below the filter) of increasing con­
centrations of histamine and metiamide. Results 
expressed as mean and standard error of the mean.
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Effects of Histamine on PMN Chemotaxis and True Chemotaxis to a Stimulus of Hydrolysed Casein
TABLE 19
The effect of varying concentration gradients and absolute concentration of Casein on the motility 
of human neutrophils in the presence and abs nee of 2 x 10“5m histamine. ^igures along the 
diagonal from upper left to lower right show the distance migrated (vim) in increasing concent a- 
tions of the leucoattractant in the absence of a concentration gradient. Above the diagonal 
cells are moving in a positive gradient. The figures in brackets are estimates of what 
migration would have been in each of the tests, assuming that the cells detected the absolute 
concentration of the chemoattractant but not the gradient.
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•vA METIAMIDE
HSTAMINE CONC (MOLAR)
Figure X A representative experiment indicating the 
effect on true PMN chemotaxis of histamine 
alone or histamine + added metiamide.
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Figure XI The effect of metiamide pre-treatment on the 
histamine induced inhibition of true chemo-
taxis
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T A B L E  2 0
a) Control - AM  2.5 x 10 M diphenylhydramine on both sides
of the f l Iter
% EAS below filter % EAS below filter
1.5 3 6 12 1.5 3 6 12
c) 2.5 x 10 histamine on both sides
of the filter
% EAS below filter
d) 2.5 x 10 cM histamine and
2.5 x 10 M dinncnyihydramine on both sides 
of the filter
% EAS below filter
The effect of varying concentration gradients and absolute concentration of EAS on the motility 
of human neutrophils in a) the absence of addi ves; and in the presence of b) diphenylhydramine 
c) histamine c.) diphenylhydramine and histamine. Figures along the diagonal from upccr l?ft to 
lower right show the distance migrated (;.n) in increasing concentrat ions of the leucoattractant 
in the absence of a concentration gradient. Above the diagonal, cells are moving in a positive 
gradient. The fiqures in brackets are estimates of what migration would have been in each of 
the tests, assuming that the cells detected the absolute c.ncentration of the chemoattractant but 
not tae gradient.
TABLE
fffectw of Dlphenylhydrnmlne on Histamine mediated stlmulatlon of ChomoklneBls 
and Inhibition of True ChomotaxlB from Data recorded In Table CT-Q
2 1
CHEMOKINES1S uM CHEMOKINCSIS uM
1. S EAS a b o v e % EAS b e  l e w D i s t a n c e I S t i n u l a t  i o n i  EAS a b o v e l  EAS b e l o w D i s t a n c e % I n h i b i t i o n
a ) C o n t r o l f  i 1 t e r f i l t e r m l q r a  t e d o f  C o n t r o l f i l t e r f  i 1 t e r m i o r a t e d TCV o f  C o n t r o l
(uni) ( urn) T r u e  C h e m o ta .x l s
1 . 5 1 . 5 64 - b) 1 . 5 3 70 5 -
3 2 6 .* - 1 . 5 6 82 16 -
6 6 72 - 1 . 5 12 91 26 -
12 12 61
2 . 2 . 5  x  1 0 " 4M 1 . 5 1 . 5 65 _ b ) 1 . 5 3 7 1 7 _
a) D ! p h e n y l h y d r a m i n e 3 3 69 - 1 . 5 6 81 13 -
6 6 71 - 1 . 5 12 91 24 -
12 12 63
3. 2 . 5  x 1 0 ' 5M 1 . 5 1 . 5 75 17 b) 1 . 5 3 69 0 100
a) H i s t a m i n e
3 3 80 2* 1 . 5 6 n 9 0 100
6 6 91 26 1 . 5 12 84 1 96
12 12 90 *8
„  - 5
4 . + 2 . 5  x 10 M i t a m i n e 1 . 5 1 . 5 82 28 b) 1 . 5 3 71 0 100
a ; 2 . 5  x 10 cl D i p h e n y l n y d r a m i n e
3 3 77 18 1 . 5 6 81 0 100
6 6 90 36 1 . 5 12 83 0 100
12 12 84 38
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Figure Xll The effect of 10 3M levamisole on histamine
induced inhibition of true chemotaxis.
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Figure Xlll -5The effect of 2.5 x 10 M histamine on the 
levamisule induced stimulation of true
chemotaxis
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a
Figure XIV The effect on intracellular cAMP (---) and
cGMP (--- ) levels after treatment with
a) histamine and b) metiamide
cGMP/p moles
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TABLE 22
Effects of Prostaglandin and Isoproterenol on PMN Chemokinesis and True Chemotaxis using
EAS as Chemoattractant
a) Control
% EAS below filter
b) 10 yg Prostaglandin E  ^
above and below 
the filter
% EAS below filter
c) 10 4M Isoproterenol above 
and below the filter
% EAS below filter
TABLE 2 3
Analysis of the Effects of PBS^, Isoproterenol and d'cAMP on Chemokinesis and
True Chemotaxis, from Data recorded in Table 22
% EAS % STIMULATION OF CHEMOKINESIS % INHIBITION OF CHEMOTAXIS
Above Below PGEj^ Isoproterenol d ’cAMP PGE^ Isoproterenol d 'CAMP
filter filter
(10 yg) (10-4M) (10"3m ) (10 uq) (10 4M) (10"3M)
a) Chemokinesis
1.5 1.5 33 25 21 - - -
3 3 29 17 40 - - -
6 6 26 21 51 - - -
12 12 24 18 75 — “
b) Chemotaxis
1.5 3 - - - 100 s 100 100
1.5 6 - - - 100 100 100
1.5 12
'
“ 100 100 100
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Effects of Propanolol on PMN Chemoklnesis and True Chemotaxis using EAS as Chemoattractant
TABLE 24
The effect of varying concentration gradients and absolute concentration of EAS on the motility 
of human neutrophils in the presence and absence of 10-4M propanolol. Figures along the 
diagonal from upper left to lower right show the distance .migrated (ym) in increasing concentra­
tions of the leucoattractant in the absence of a concentration gradient. Above the diagonal, 
the cells are moving in a positive gradient. The figures in brackets are estimates of what 
migration would have been in each of the tests, assuming that the cells detected the absolute 
concentration of the chemoattractant but not the gradient.
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DISCUSSION
In a series of pioneer experiments using 
a classical Boyden technique, histamine appeared 
to increase both directed and random motility of 
PMN. To determine whether the effect on chemo- 
taxis was any different from the effect on random 
migration, true chemotaxis was assessed according 
to the method of Zigmond and Hirsch (1973). This 
technique permits an accurate assessment of the 
degree and type of cell motility affected by agents 
under investigation. The results indicate that the 
stimulatory effect of histamine is attributable 
entirely to an increase of chemokinesis. Not only 
is there no enhancing effect on true chemotaxis but 
marked inhibition is evident, an e"cect which is 
masked in t;he classical Boyden system and which 
emphasises the importance of the method of Zigmond 
and Hirsch in enabling correct ‘interpretation. Such 
a phenomenon of stimulation of chemokinesis with 
concomitant inhibition of true chemotactic responsive­
ness has been previously described in association 
with the effect of colchicine on lymphoblast motility, 
(Russellet at3 1975).
The histamine induced increase of chemokinesis 
and the inhibition of true chemotaxis was dose 
dependent being maximal at 2.5 x 10 ^M, and the 
inhibition was evident when both EAS or hydrolysed
151 .
casein were used as chemoattractants. Activation 
of PMN by these two chemotactic substances is 
probably dependent upon different mechanisms 
(Rabson et ah 1976) and the finding that histamine 
inhibits chemotaxis to both agents suggests that it 
is acting on a common pathway.
Several leucocyte functions are known to be 
modulated via histamine receptors, which are of 
two types as shown by Ash and Schild (19 66) , The 
H-l receptor which mediates the contraction of 
intestinal and bronchial smooth muscle and the 
dilation of small venules has been shown to have 
no effect on histamine modulation of either eosino­
phil (Clark et alt 1975) or neutrophil (Hill and 
Quie, 1975) chemotaxis. The H-2 receptor, which 
mediates gastric acid secretion, has been observed 
to modulate both T-cell function (Plaut et al3 1975) , 
and the histamine effects on eosinophil (Clark et al} 
1975) and neutrophil movement (Hill and Quie, 1975;
Hill et cZ., 1975). Using diphenylhydramine hydrochloride 
a potent H-l receptor blocking agent, no effect on 
either the histamine induced stimulation of random 
migration or the inhibition of true chemotaxis could 
be demonstrated in the present study. These results 
are in agreement with those of Hill and Quie (1971) who 
showed that the histamine induced inhibition of chemo­
taxis was independent of the H-l receptor site, but
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could be eliminated by an H-2 receptor antagonist. 
Similarly Clark et at, (1975) have reported that 
eosinophil chemotaxis to 'excess histamine concentra­
tions is potentiated by metiamide but not by an 
H-l receptor blocker. In this study metiamide, 
an H-2 receptor antagonist had no detectable effect 
■per se on true PMN chemotaxis although it did 
stimulate random migration, indicating that it ' 
was able to mimic (albeit weakly) the histamine 
effect on this latter function. These results 
suggest that random migration is enhanced by 
occupation of the H-2 receptor site. Because 
metiamide alone increased chemokinesis, its 
effects on the previously noted histamine stimula­
tion of chemokinesis were not investigated. The 
H-2 receptor antagonist was, however, capable of 
blocking the hisuamine induced inhibition of true 
chemotaxis, a phenomenon which.was irreversible 
and which was dependent upon pre-treating the cells 
with metiamide.
The diverse effects of histamine and metiamide 
on PMN directed motility suggests that metiamide 
weakly simulates histamine to an extent sufficent 
to exert a stimulatory effect on chemokinesis but 
insufficient to affect true chemotaxis. These 
results indicate that the two-fold effect on neutro­
phil motility induced by histamine may be mediated 
via the H-2 receptor site.
To assess whether levamisole, a potent stimulator 
of all forms of neutrophil movement mediates its 
effects via the H-2 receptor s-ite, cells were pre­
treated with metiamide and exposed to levamisole.
Results indicate that metiamide is unable to block 
levamisole induced stimulation of chemotaxis, which 
probably acts independently of the H-2 receptor.
Histamine pre-treatment of neutrophils, however, 
excluded levamisole stimulation, whereas levamisole 
pre-treatment prevented histamine induced inhibition of 
chemotaxis. The opposite effects of histamii e and 
levamisole, unrelated to the H-2 receptor site, may 
pertain to their diverse influence on intracellular 
cyclic nucleotide levels (see later).
Histamine has been reported to increase intracellular 
levels of cAMP. More specifically, increases have been 
noted in human lung slices and basophil preparations 
(Beaven, 1976) mononuclear cells (Bourne et at, 1973) 
and neutrophils (Zurier et at, 1974) . Cyclic nucleotide 
estimations in this report indicate that PMN cAMP levels 
are significantly increased after histamine treatment 
reaching maximum levels within 5 minutes and persisting for 
Lhe remainder of the experiment. Cells treated with 
metiamide, however, showed an initial slight elevation 
of cAMP which soon returned to normal levels. Intra­
cellular cGMP levels were unaltered by exposure to either
histamine or metiamide.
Agents which promote fluctuations in intra­
cellular cyclic nucleotide levels have previously 
been shown to modulate neutrophil movement. Hill 
et al, (.1975) have demonstrated. that histamine and
other agents which increase intracellular levels of 
cAMP inhibit PMN chemotaxis, their results being 
similar to those of Rivkin et at, {''SI5) and Tse 
et al, (1972). Rivkin and Becker (1976) hav^ also
reported that d 'cAMP stimulates random migration but 
inhibits chemotaxis, and these agents induce 
enhanced Pk\T migration from capillary tubes 
(Loranitzer et al} 1976). In the present study, PGE^, 
isoproterenol and d'cAMP, agents known to increase 
intracellular levels of cAMP all simulated the effects 
of histamine in stimulating chemokinesis but inhibiting 
true chemotaxis. cAMP, an agent which does not enter 
cells (Henion et al, 1967) had no effect on either of 
these functions. Although these results suggest a 
relationship between increased cyclic AMP levels and 
enhanced random motility, propanolol, a 3-blocker 
also stimulates chemokinesis and true chemotaxis, as 
does ievamisole, an agent which does not affect cAMP 
but which increases leucocyte intracellular cGMP 
levels (Hadden et al, 1975). This might indicate the 
existence of at least 2 distinct modes of stimulation 
of random motility. The first being related to 
increased levels of cAMP which may mediate stimulation 
by decreasing cell adherence (Lomnitzer et al, 1976) 
and the second by agents which do not elevate cAMP
levels (Hadden et at, 1975 and Haddock 6. al, 1975) , 
and have no effect on adhesion. The mechanism of 
stimulation by the latter is unknown. These results 
also indicate that the Yin-Yang hypothesis of biologic 
control (Goldberg et aZ_,1974) may not apply to 
neutrophil random motility.
As regards true PMN chemotaxis, however, it does 
appear that agents which increase intracellular levels 
of cAMP will inhibit this function whereas levamisole 
and propanolol which increase cGMP levels, also promote 
enhancement of directed motility.
C H A P T E R  VIII
Effects of Leucoattractants (Casein and EAS) and 
Drugs which alter Intracellular Cyclic Nucleotide 
Levels on Neutrophil Glycolysis and Hexose Monophosphate
Shunt Activity
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INTRODUCTION
The results documented in the previous three 
chapters have indicated that‘drug-induced increases 
in intracellular cyclic nucleotide levels promote 
altered PMN locomotory responses. Neutrophil chemo- 
taxis is a glycolysis dependent phenomenon (Carruthers, 
1966; Goetzl and Austen,1974)and hexose monophosphate 
shunt activity has also been implicated in cell 
motility (Goetzl et al, 19 74; Goetzl and Austen, 1974).
To assess whether the obseived changes in cell motility 
mediated by cAMP and cGMP were related to changes in 
glycolytic or HMS activity the effects on these path­
ways of drugs which cause elevation of intracellular 
cyclic nucleotides have been investigated in neutrophils 
stimulated by leucoattractants. To evaluate functional 
specificity the effects of these drugs, and also of the 
chemoattractants EA3 and casein on HMS activity follow­
ing phagocytosis of Candida albicans, have been 
determined.
MATERIALS AND METHODS
Chemicals: The drugs used in the present study were
cAMP, d'cAMP, isoproterenol, histamine, prostaglandins 
E^ and A^, cGMP, levamisole, propanolol, acetyl choline 
and carbamyl choline. The commercial sources of these 
drugs have been indicated in previous chapters.
Ascorbic acid was obtained from Sigma Chemicals 
(St. Louis, Missouri, U.S.A.).
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Neutrophil preparation: For all investigations 
described in this study pure neutrophil suspensions 
were used. Heparinized venous blood was obtained 
from healthy donors and neutrophils were prepared 
according to the procedures described in 
Chapter iv (page 49).
Glycolysis assay: Glycolysis was assessed according 
to the extent of lactate production by 6 x 10^ PMN 
in the presence of leucoatrractants and the various 
drugs. Experiments were of two types. Firstly 
kinetic experiments were performed at 1, 3, 5, 10,
20, 40 and 60 minutes to investigate the effects on 
glycolysis of casein (at a final concentration of 
lOOy-cg/O.5 ml.), serum (6%) and EAS (6%). The control 
system was PMN in PBS alone. The efl rts of d 'cAMP 
histamine, levamisole and propanolol on EAS stimulated 
glycclysis were also investigated at the same time 
intervals. In a further series of experiments the 
effects of the leucoattractants and drugs at a fixed 
time interval (60 minutes) were assessed. Drug effects 
on glycolysis were investigated in the presence and 
absence of 5% EAS.
Hexose Monophosphate Shunt A s s a y : HMS activity of
4 x 106 neutrophils was assessed by measurement of the
14amount of radiolabeled C02 (1 - C02) released from
14glucose labelled in the C-l position. The CC>2
released during incubation was absorbed in IN KOH.
14The amount of absorbed CC>2 .is proportional to the
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extent of IIMS activity. The IIMS assay procedure 
is described in Chapter IV(page 68).
In an initial series of experiments the effects 
of chemoattractant stimulation (casein and EAS at 
final concentration of 100 yg and 10% respectively) 
and phagocytosis (by the ingestion oi C. albicans) 
were assessed at varying time intervals (1, 3, 5,
10, 20, 40 and 60 minutes). In dose response experi­
ments a fixed time interval (60 minutes) was selected 
and the effects of d'cAUP (10 ~*M - 10 M^) , histamine 
(10 - 10 ^M), levamisole (10 - 2.5 x 10 M^)
— 6 — 7and propanolol (10 M - 10 M) on EAS stimulated
neutrophils, were investigated. In further kinetic
experiments the effects of the same drugs i.e. d'cAMP,
histamine, levamisole, propanolol ani. also ascorbic
acid were assessed at varying time intervals at
-3 -5 -3fixed concentrations of 10 M, 2.5 x 10 M, 10 M and 
-410 M respectively. The effects of the leucoattractants, 
cyclic nucleotides and various drugs were also tested 
at fixed time intervals (60 minutes) and at fixed 
concentrations. Cyclic nucleotide and drug effects 
were evaluated in the presence of 10% EAS. A similar 
series of experiments were performed to assess the 
effects of the same agents on neutrophil phagocytosis. 
Phagocytosis was initiated by the addition of 0,1 ml.
Calbicans containing 8 x 10^ organisms/ml, to give a 
final cell : particle ratio of 1 : 2. For opsonization
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0.1 ml. of autologous serum was added to the 
reaction mixture. Using this system 90% - 100% 
ingestion is evident at 20 minutes (Rabson et al, 
1974).
Nltroblue Tetrazolium Reduction: N .B.T . reduction 
v:as measured by a semi-quantitative slide technique 
which has been described in Chapter TV (page 69).
The effects of the leucoattractants casein and EAS 
at final concentrations of 100 yg and 10% respec­
tively were assessed.
RESULTS
Glycolysis: The effects of EAS, serum and casein
on the kinetics of lactate production are shown in 
Fig. XV (page 162). Results are expressed as mean and 
standard error of the mean values for five separate 
experiments. As can be seen, EAS causes a marked 
stimulation of glycolysis at all time intervals 
whereas no such stimulation is mediated by serum 
alone or casein. Dibutyryl cAMP, histamine, 
levamisole and propanolol were without effect on 
glycolysis at all time intervals tested (results not 
shown). The results of experiments investigating ihe 
effects of the leucoattractants, cyclic nucleotides 
and various drugs are shown in Table 25 (Page 163). 
These results are expressed as mean values with 
standard deviations of six experiments. As can be 
seen only EAS mediated a stimulation of glycolysis. 
Cyclic nucleotides and drugs had no effect on the 
EAS stimulation of glycolysis.
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HMS: The effects of phagocytic and < ' emoattractant
stimulation on HMS activity are shown in Figure XVI 
(page 164). Results are expressed as mean values 
and standard error of the mean for three separate 
experiments. Phagocytosis causes a considerable 
increase in HMS activity (400% at 60 minutes) where­
as the effects of chemotactic stimuxation vary with 
the leucoattractant. EAS promotes a delayed 
stimulation which is only evident at 60 minutes, 
whereas casein mediates considerable inhibition of 
the HMS which is present at all time intervals 
tested. Results of experiments utilising serum have 
been corrected for serum inhibition. Serum alone 
promotes an inhibition of HMS activity which is 
presumably due to a competitive effect of serum 
glucose. It is unlikely that the i.mibition is 
mediated by inhibition of adherence due to high 
protein- concentrations since media supplemented with 
equivalent concentrations of non-chemotactic bovine 
serum albumin has no inhibitory effect. Furthermore, 
siliconisation of the cell containing chamber had 
no inhibitory effects, which would indicate that 
HMS activity is probably not adherence dependent.
The results or six separate (mean and standard 
error) dose-response experiments for d 'cAMP and 
histamine are shown in Figure XVII (page 165) and of 
levamisole and propanolol in Fig. XVI11 (page 166), As
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can be seen all four agents mediate a progressive
dose dependent inhibition of HMS activity. Figures
XIX, XX, XXI and XXI1 on pages 167, 168, 169 and
170 respectively, show the kinetics of EAS
associated HMS activity in the presence and absence
of the same four drugs. Inhibition is evident
throughout, and is greatest at 60 minutes. These
results have not been corrected for serum inhibition,
since the magnitude of inhibition is unaltered. Tne
-3effects of ascorbate (5 x 10 M) on HMS activity in 
the absence of EAS or phagocytosis are shown in 
Figure XX111 (page 171). The results are expressed 
as mean values for triplicate samples cf one experi­
ment. Ascorbate promotes considerable stimulation of 
HMS activity (300% at 60 minutes) which is evident 
at all time intervals. Table 26 (page 172) shows the 
results of drug effects on EAS associated IIMS activity 
after 60 minutes incubation. Those which mediate 
elevated intracellular cAMP cause a depression of HMS 
activity. Levamisole and propanolol mediate similar 
effects whereas cGMP, acetyl choline and carbamyl 
choline have no effect. Ascorbate promotes enhance­
ment of HMS activity in the presence of EAS.
The effects of the leucoattractants casein and 
EAS, and of certain drugs which mediate depression of 
the HMS, on HMS associated phagocytosis are shown in 
Table 27 (page 173). Casein and EAS have no effects 
on neutrophil HMS activity associated with phagocytosis 
whereas all other agents tested cause inhibition.
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Figure XV The effects of PBS (A), Casein (©), Serum (x) 
and EAS (o) on the kinetics of neutrophil
glycolysis.
TABLE 25
Effects of 1) Casein, EAS and Autologous Serum and 2) EAS in the Presence of
Various Drugs on Neutrophil Glycolysis
Final Concentrations of Drugs 
and Leucoattractants added 
to 6 x 10 ^PMN
Mean Lactate Production 
ug/6 x 106 PMN/60 Min, 
with Standard Deviation
PBS only 9.8 + 1.2
Casein. (100/* g/ml.) 10.2 + 0.98
Serum (6 o) 12.2 -f 1.5
EAS (6'O )-3 d 'cAMP.
39.3 + 4.1
EAS + 10 M -3 38.6 + 3.3EAS + 10 M-3 CAMP 39.1 + 3,6EAS + 10 M 
.-3
cGMP 40.2 + 4-0
EAS + 10 M isoproterenol -5 , 40.1 + 3.2EAS + 2.5 x 10 M histamine 38.2 + 3.6
EAS + 10 yg PGEX 41.2 + 3.5
EAS + 10 pg -3 PGAX 40.0 + 4.1EAS + 10 M levamisole 39.6 + 3.7
EAS + io-4m propanolol 38.3 + 4.0
EAS + io-3m-3 acetyl choline 39.6 + 3,8EAS j. 10 M carbamyl choline 40.1 + 3.6
I 0 3
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Figure XVI The effects of chcmotactic and phagocytic 
stimulation on neutrophil IIM5 activity. 
Resting (o), Casein (o) and EAS effects (x) 
are shown in the lower graph and phagocytosis 
(e) in the upper graph.
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Figure XVI1 The effects of varying dibutyryl cAMP
and histamine concentrations on 
neutrophil HMS activity.
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LEVAMISOLE CONC.( MOLAR)
Figure XV111 The effects of varying concentrations of 
levamisole and propanolol on neutrophil
HMS activity
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Figure XIX
_3The effects of 10 M aibutyryl CAMP (o)
on the kinetics of EAS associated RMS
activity(© control).
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Figure XX The effects of 2.5 x histamine
(o) on the kinetics of EAS associated
HMS activity, (© control).
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Figure XXI The effects of 10 3M levamisole (o) on the
kinetics of EAS associated HMS activity,
(o control).
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Figure XX11 The effects of 10~4M propanolol (o) on the 
kinetics of EAC. associated HMS acLivity,
(o control).
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Figure XXI11 The effects of 5 x 10 3M ascorbate on
neutrophil resting HiiS activity.
TABLE 26
, _ , „ oll,,lir Cvclic Nucleotide Levels on EAS
Effects of Various Drugs which^romote Elevation_o^— —
■i _ j___ .1 n u c  A r f  i v i  h v
Drug Concentration
cAMP 1 x 10-3M
d 'cAMP 1 x 10"3M
Histamine 2.5 x 10"5M
Isoproterenol 1 x 10"4M
Prostaglandin 10 yg/ml.
Prostaglandin E. 10 ug/ml.
cGMP 1 x 10"3M
Acetyl c:holine 1 x 10"3M
Carbamyi choline 1 x ]0”~M
Ievamisole 1 x 10"3M
Propanolol 5 x 10"4M
Ascorbic Acid 5 x 10"3M
Control 
S tandard
Mean and 
Deviation
Experimental Mean 
and
Standard Deviation
2 9 1 3 + 7 0 8 2 6 9 8 + 5 8 9
2 0 3 2 + 4 4 9 1 0 7 3 + 1 3 5
2 1 9 3 + 7 0 8 1 9 2 9 + 515
2 1 9 3 + 7 0 8 2 0 7 9 + 5 0 8
2 1 9 3 + 7 0 8 1 4 6 2 ±  6 1 2
2 1 9 3 + 7 0 8 1 6 4 2 + 4 1 5
2 1 9 3 + / 0 8 2 7 7 9 + 7 6 9
2 1 9 3 + 7 0 8 2 7 2 7 + 50 6
2 1 9 3 + 7 0 8 2 8 9 8 + 7 50
2 6 0 8 + 6 2 6 1 3 6 7 + 4 2 5
3 1 2 3 + 3 9 5 1 3 8 0 + 67 5
2 2 0 3 + 4 4 2 3 3 1 2 + 5 0 0
Inhibition 
of Control p Value
7 . 3 NS
47 p  < 0 . 0 0 1
34 p  < 0 . 0 0 1
29 p  < 0 . 0 1
50 p  < 0 . 0 0 1
44 p  < 0 . 0 0 1
4 . 6 MS
6 . 3 NS
- NS
48 p  < 0 . 0 0 1
56 p  < 0 . 0 0 1
+ 50  * p  < 0 . 0 0 1
^(Stimulation)
TABLE 27
Effects of Casein, EA5, d 1cAMP, Histamine, Isoproterenol, Levamisole and Propanolol on HMS Activity
Associated with’ Phagocytosis
Leucoattractant Control Mean Experimental Mean % Inhibitionor Concentration and and of £_valueDrug Standard Deviation Standard Deviation Control
Casein 100 pg/ml. 28306 + 3331 30220 + 6395 0 NS
EAS 10% 28306 + 3331 28262 + 2418 0 NS
d ' cAMP 1 x 10-3M 33579 + 5557 17233 + 4187 49 P < 0.001
Histamine 2.5 x 10~3M 33579 + 5557 20156 + 3618 40 P < 0.001
Isoproterenol 1 x 10_4M 33579 + 5557 27555 4- 3217 18 P < 0.05
Levamisole 1 x 10_3M 32946 + 5839 22892 + 2611 31 P «—1 CT •OV
Propanolol 1 x 10~4M 33579 + 5557 20054 + 3061 40 P < 0.001
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The effects of the leucoattractants casein 
and EAS on N.B.T. reduction, are shown below in 
Table 28.
TABLE 28
The Effects of Casein and EAS on 
Neutrophil Nitroblue Tetrazolium Reduction
CASEIN STUDY EAS STUDY
.
Casein 
ICO yg
Endotoxin and EndotoxinControl Control Heat inactiv- and Normal
ated Serum Serum (EAS)
1.2 + 1.5 0.9 + 1 1.7 + 1.5 19 + 3 31 + 8
Casein has no statistically significant erfect on 
N.B.T. reduction whereas EAS mediates a significant 
increase above the control which contains serum and 
endotoxin which had been inactivated by heating at 
56°C for 40 minutes. (p < C.01)
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DISCUSSION
Glycolysis has been implicated directly and 
indirectly, as being the major source of adenosine 
triphosphate (ATP) production for neutrophil chemo- 
taxis. However, casein, another potent chemoattrac­
tant, had no effect on glycolysis over a one-hour 
period, indicating that although glycolysis per se 
might be essential for optimal leucotaxis, 
stimulation of this pathway is not a pre-requisite 
for cell motility. These different effects on 
glycolysis could reflect different activities 
and modes of action of the two chemoattractants 
used, EAS being the more potent of the two 
attractants.
Drugs known to increase neutrophil random 
motility and chcmotaxis, such as levamisole and 
propanolol had no effect on glycolysis, the results 
being similar to those described for ascorbic acid. 
Histamine, d'cAMP, prostaglandin E^  and isoproterenol, 
agents which increase random motility but which 
inhibit true chemotaxis also had no effect on this 
pathway, these results indicating that enhancement of 
cell motility, either directed or random, is not 
dependent upon stimulation of glycolysis. Goetzl 
and Austen (197d) have reported that the partially 
purified chemotactic factors C5a and kallikrein, 
mediate ICO - 600% increases in HMS activity above 
that of the corresponding unstimulated cells. The 
increase in HMS activity with time parallels the
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neutrophil chemotactic responsiveness and similar 
results were obtained in this study using EAS.
Goetzl et at, (1974) have reported that 
ascorbic acid and glutahione which may enhance 
the oxidation of NADPH to NADP+ (De Chatelet et 
at, 1972) the early rate limiting step in the 
HMS promote a stimulation of neutrophil chemotaxis 
and random migration.
The work of these authors has implicated 
HMS involvement in neutrophil motility, increased 
HMS activity being associated with an enhanced 
level of motility. However, there is evidence to 
suggest that stimulation of the HMS associated with 
neutrophil locomotion may be coincidental. It has 
been demonstrated that DFP (Carruthers, 1966) and 
neutrophil-immobilising factor (Goetzl et at, 1973) 
which cause suppression of neutrophil chemotaxis 
have no inhibitory effects on HMS activity. Further­
more although EAS has been shown to stimulate HMS 
activity, as does kallikrein and pure C5a, casein 
promotes a consistent depression of resting HMS 
activity confirming that HMS stimulation is not 
essential for cell movement. Goldstein ct at,
(1975) have reported that biochemically pure C5a 
caused a stimulation (500%) of nitroblue tetrazolium 
(N.B.T.) reduction by human neutrophils v.’ith a 
concomitant 350% increase in HMS activity.
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The divergent effects of the two chemotactic 
factors, EAS and casein, were further confirmed 
using N.B.T. reduction. • Wherease EAS consistently 
stimulated N.B.T, reduction, casein had no effect 
on this function. Furthermore although ascorbic 
acid which increases all forms of cell movement 
stimulates HMS activity, other drugs with similar 
effects on cell motility such as levamisole and 
propanolol decreased HMS activity. In addition, 
drugs which apparently raise intracellular cAMP 
levels (acetyl choline, carbamyl choli. ; and cGMP) 
have been reported to alter cell motility 
(Estensen ct at, 1973)(results which could not be 
confirmed in this laboratory) also had no effect 
on HMS activity. Drugs which cause increased 
intracellular accumulation of cAMP also had no 
stimulatory effect on HMS activity and in fact 
decreased the HMS pathway. Furthermore, PGA^ at 
a concentration known to inhibit all forms of 
neutrophil movement (Rabson et at, 1974) also 
depressed HMS activity, indicating a lack of 
relationship between stimulation and inhibition of 
neutrophil movement and HMS activity.
It was of interest that although casein 
depressed HMS activity in resting cells, it was 
unable to inhibit the metabolic burst associated 
with phagocytosis, EAS likewise had no effect. On 
the other hand levamisole, propanolol and drugs
1 7 8 .
known to increase intracellular cAMP le/els 
were able to inhibit the'post-phagocytic increase 
in HMS activity.
The results described in this paper indicate 
that although an intact glyco]ytic pathway is 
probably necessary for cell motility, since 
inhibitors of this pathway cause depressed cell 
motility, stimulation of glycolysis is not a pre­
requisite for cell motility. Furtherm e 
alterations in HMS activity are unrelated to the 
effects on cell motility since agents which 
induce inhibition (levamisole and propanolol) 
have the same effects on locomotion as ascorbic 
acid which causes stimulation of the HMS.
In addition casein, a potent chemoattractant, did 
not stimulate HMS activity, this depressive effect 
being specific for resting cells since HMS activity 
associated with phagocytosis is unaffected by 
casein. Finally, this study has indicated that 
the two chemoattractants, FAS and casein, have 
different effects on cellular biochemistry.
C H A P T E R  IX
Discussion
i v y .
The results presented in this thesis indicate 
that agents which promote changes in neutrophil 
intracellular cyclic nucleotide levels can also 
modulate cell motility. Exogenous cAMP and cCMP 
are without effect on motility, presumably due to 
poor intracellular passage. Various agents whi^h 
promote elevated cAMP levels by different modes 
of stimulation such as d 'cAMP, histamine, prosta­
glandin E ^ and isoproterenol,all mediate a dose 
dependent stimulation of random motility and 
chemoKinesis with a concomitant inhibition of 
true directed motility. Microtubular synthesis, 
which is probably essential for chemotaxis, is 
a cAMP dependent process (Fuller et cl, 1975). 
However, the maintenance of artifically high 
levels of intracellular cAMP may mediate inhibition 
of microtubule synthesis. On the other hand cAMP 
may innibit some other cell function necessary 
for chemotaxis. A possible contender for this 
role is cell adherence. Certain of the above 
drugs (d'cAMP and prostaglandins) have been reported 
to inhibit PMN adherence in vitro (Lomnitzer et al t 
1976a), with an accompanying increase in the area 
migrated from capillary tubes. It is possible, 
therefore, that the increased random motility 
caused by these ayents is mediated by a decreased 
adherence to the substratum thereby facilitating
such movement.
1 8 0  .
Directional movement on the other hand, .lay require 
adherence for cell orientation and agents which 
inhibit this function could be expected to interfere 
with chemotaxis.
The effects obtained with agents which promote 
elevation of intracellular cGMP levels are somewhat 
different. Although the results of Estensen et at,
(1973) and Hill et at, (1975) could not be confirmed, 
two other agents which can promote elevated cGMP 
levels, levamisole and propanolol, exerted profound 
effects on cell motility. Both drugs caused a marked 
stimulation of random motility and chemokinesis.
However, no inhibition of true directed motility was 
observed, rather stimulation was evident. The 
mechanism of stimulation of random mot'Lity by these 
drugs is probably different to that of cAMP stimulants 
since the effects on chemotaxis are different and also 
levamisole and propanolol have no effects on neutrophil 
adherence (Lomnitzer, 1976, unpublished observations).
It is, therefore, likely that the effect of cGMP is due 
to a stimulation of a common component in the machinery 
of random migration, chemokinesis and chemotaxis. 
Furthermore ascorbic acid which has been reported to 
increase neutrophil random migration and chemotaxis 
(Goetzl et al} 1974) has also been reported to increase 
neutrophil intracellular cGMP levels (Gallin and Wolff, 
1975). The effects of ascorbate on neutrophil migra­
tion have been confirmed by the author in this laboratory, 
although the precise types of motility affected have not 
been studied. The altered cell motility due to cGMP
can probably be considered as a direct positive 
stimulation whereas that mediated by cAMP on random 
motility and chemotaxis is secondary and indirect 
since the primary effect is probably on cell adherence,
Casein and EAS showed a different spectrum of 
effects on HMS and glycolytic activities and on 
cyclic nucleotide profiles. EAS promoted an early 
increase in cAMP levels, and a stimulation of glyco­
lysis, the IIMS and N.B.T. reduction. Casein, however, 
caused no stimulation of either intracellul cAMP, 
glycolysis or N.B.T. reduction and actually mediated 
a depression of HMS activity. These results would 
indicate that an early elevation of cAMP and stimula­
tion of glycolysis and the HMS are not prerequisites 
for cell motility. Intact glycolysis is probably 
necessary for cell motility since inhibitors of this 
pathway cause depressed cell motility. Furthermore 
the capacity of a leucoattractant to activate glycolysis 
may correlate with leucotactic activity. This is indeed 
the case with EAS and casein, the former being the more 
potent of the two leucoattractants. Chemoattractants 
may, therefore, be of two types; firstly those which 
mediate little or no change in cyclic nucleotide levels 
and glycolysis and HMS activity; and secondly those 
which promote changes in all 3 functions. The former 
may be considered as "passive" and the latter as "active" 
leucoattractants. The relationship of the early increase
in cAMP, mediated by EAS, to glycolysis is obscure. 
Although the increase in glycolysis parallels the 
early peak of cAMP synthesis,- agents which promote 
elevated c/iMP levels in neutrophils have no effect 
on glycolysis.
On the other hand agents which stimulate random 
motility caused a depression of HMS activity. The 
exception to this finding is ascorbic acid which pro­
motes a stimulation. These findings would indicate 
that alterations in HMS activity are unrelated to the 
effects on c^ll motility since agents which induce 
inhibition (levamisole and propanolol) rave the 
same effects on locomotion as ascorbic acid which causes 
stimulation of the HMS. The depressive effect of casein 
on the HMS was specific for resting cells since HMS 
activity associated with phagocytosis is unaffected by 
this leucoattractant. Agents which promote effects on 
intracellular cAMP levels and levamisole and propanolol 
which increase cGMP levels cause a functionally non­
specific inhibition of HMS activity since chemotaxis and 
phagocytosis are both affected.
In conclusion cell motility can be modulated by 
agents which mediate alterations in intracellular cyclic 
nucleotide levels. Elevated cAMP and cGMP levels promote 
enhanced random motility which is probably a similar 
manifestation of different effects. The two cyclic 
nucleotides mediate opposing effects on directed motility
cAMP causes inhibition and cGMP stimulation. The 
effects o^ the cyclic nucleotides are probably unrelated 
to glycolysis and HM3 activity. The two leucoattractants 
used iii this study have different effects on cellular 
biochemistry. Although th« mechanics of movement are 
probably the same the respective capacities tc mobilize 
intracellular energy sources are different.
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ADDENDUM
A criticism of experiments presented in 
Chapters VI and VII of this thesis is the absence 
of control experiments to investigate the 
leucotactic potential of the drugs (D'cAMP, 
histamine, isoproterenol, levamisole and propranolol) 
at concentrations which stimulate neutrophil 
chemokinesis in the absence of any protein leuco- 
attractant. This criticism is motivated by the 
possibility that the various drugs at the concentra­
tions used may produce their observed effects by a 
combined action on leucocyte chemotaxis and 
chemokinesis. This criticism is invalid for the 
drugs levamisole and propranolol for the following 
reasons:
1) In the checkerboard systems used to dissociate 
effects on random and directed movement the various 
drugs were present in equimolor concentrations on 
both sides of the filter for all systems investigated, 
i.e. random migration, chemotaxis, chemokinesis and 
motility in negative gradients. At no time was a 
drug gradient present, therefore chemotactic effects 
can be excluded.
2) Levamisole and propranolol in equimolar concentra­
tions on both sides of the filter actually enhance 
directed motility in positive gradients of EAS. This 
excludes the possibility that these drugs are themselves
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chemotactic since no increment in directional motility 
should occur if they were attractants. In fact the 
extent of migration should not increase, but should 
remain the same or diminish due to a deactivation 
effect if the drugs themselves were chemotactic. On 
the other hand the drugs which increase intracellular 
cAMP levels cause an inhibition of the neutrophil 
directional response to EAS and casein when present on 
both sides of the filter. The criticisms presented 
may be valid for these drugs since deactivation of 
directional motility could be explained if D'cAMP, 
histamine and isoproterenol were chemotactic. Their 
presence on the upper side of the chamber may 
eliminate neutrophil chemotactic responsiveness.
However a more detailed examination of the checker­
board results indicates it is unlikely that these 
drugs have leucotactic potential due to their stimula­
tion of motility in negative gradients of EAS.
Likewise in chemokinesis systems the stimulation of 
random motility is equal to or greater than that of 
the corresponding positive gradients. For both 
negative gradients and chemokinesis systems it could 
be expected that a reduction in motility due to the 
combined "deactivating" effects of EAS and "chemotactic" 
drug would occur. This was not observed and 
indicates the improbability that cAMP elevating drugs
are chemotactic.
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Early experiments using the Boyden system 
indicated that the drugs levamisole, D 'cAMP and 
histamine were not chemotactic. These results 
were not included in this thesis since in the 
opinion of the author, all necessary information 
on the mode of action of these agents on cell 
motility could be obtained from data contained in 
the checkerboard systems. However, to clarify 
this matter and to conclusively answer criticisms 
of this investigation, these experiments have been 
repeated using levamisole, D'cAMP, histamine, 
isoproterenol and propranolol at concentrations 
used in the checkerboard systems and which have 
been shown to have optimal effects on neutrophil 
motility. By placing each drug in the upper com­
partment only and the lower compartment only and in 
both compartments simultaneously, the chemotactic 
activity of the drugs can be assessed. Should a 
given drug be chemotactic the extent of migration 
in the positive gradient should exceed that in the 
absence of a gradient and in the corresponding 
negative gradient. If the drug possesses only chemo- 
kinetic activity the extent of migration should be 
equal in all three systems or greater in the absence 
of a positive gradient. The method of Zigmond and 
Hirsch (1973) has been used to investigate these
effects.
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MATERIALS:
The drugs used were levamisole, propranolol, 
D'cAMP, histamine and isoproterenol.
CHEMOTAXIS ASSAY:
The method used was that of Zigmond and 
Hirsch (1973) as described in Chapter V page 72. 
Drugs used were placed in appropriate concentra­
tions on either or both sides of the Boyden 
chamber. Neutrophils were not preincubated with 
drugs. No added protein was present in the system 
since the purpose of the study was to determine 
the leucotactic potential of the various drugs.
RESULTS;
These are shown in Table 29, page 200. 
Neutrophil migration is expressed as mean and 
standard deviation for 3 experiments each with 
triplicate filters. A chemokinetic effect was 
observed for all drugs tested. The chemokinetic 
effect was independent of the chamber placing of 
the drug. The extent of neutrophil migration when 
drugs were placed in the lower chamber only did not 
exceed that observed when the drug was present in 
the upper chamber only or in both the upper and 
lower chambers. This was true for all drugs tested 
and shows convincingly that none of these drugs are
leucotactic.
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DISCUSSION:
Drugs investigated in this thesis which 
mediate their effects on leucocyte motility by 
increasing intracellular cyclic nucleotide 
levels are not leucotactic. Although the 
conclusions in this thesis pertaining to levami- 
sole and propranolol effects on leucocyte 
motility are valid without further experiment 
the conclusions contained in Chapter VII on the 
effects of cAMP elevating agents on leucocyte 
motility could be invalidated if these drugs are 
chemotactic. However the results contained in 
the checkerboards indicate that this is unlikely 
due to stimulation of chemokinesis and motility 
in negative gradients. Furthermore the experiments 
contained in the section confirm that none of the 
drugs tested are chemotactic and that the conclusions
are accurate and valid.
TABLE 29
ASSESSMENT OF THE LEUCOTACTIC POTENTIAL OF DRUGS WHICH 
STIMULATE NEUTROPHIL CHEMOKINESIS
Drug Concentration
DISTANCE MIGRATED (ym) WITH DRUG I N :
1 2  3
Lower Chamber 
only
Upper Chamber 
only
Both upper 
and
lower chamber
D1cAMP 2.5 X io-3m 38.8 ± 5.1* 40.1 + 4.0 41.3 + 6.2
Histamine 2.5 X io~5m 38.3 ± 2.96 43.3 ± 5.4 42.8 + 5.7
Isoproterenol 1 . 0 X io“3m 36.3 ± 4.5 37.2 + 5.1 38.2 ± 4.2
Levamisole 1 . 0 X io-3m 46.6 ± 4.6 46.5 + 6.7 45.6 ± 4.3
Propranolol 1 . 0 X -410 M 42.0 ± 7.4 43.2 + 6.5 44.1 ± 7.1
* Results are expressed as mean value with standard deviation. The mean value for 
the control (no drugs) experiments is 28.3 ± 7.4.
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